Exploring the Possibilities of Proton Therapy

At the University of Florida Health Proton Therapy Institute, confidence doesn’t just come from the cancer treatments we provide to our patients every day. We draw confidence from the unexplored possibilities of cancer treatment. What’s more, we work every day to expand the power of proton therapy – for today’s patients, and tomorrow’s.

UF Health Proton Therapy Institute published research:

Comparsion of Proton Therapy (left) versus IMRT (right)
Comparsion Image - Proton Therapy is on the left, IMRT is on the right.

Publications 2005 - Present

Last updated June, 2021

  1. Rutenberg MS, Rotondo RL, Rao D, Holtzman AL, Indelicato DJ, Huh S, Morris CG, Mendenhall WM. Correction to: Clinical outcomes following proton therapy for adult craniopharyngioma: a single institution cohort study. J Neurooncol. 2021 Apr;152(2):415. doi: 10.1007/s11060-021-03740-8. PMID: 33751336.
  2. Upadhyaya SA, Robinson GW, Onar-Thomas A, Orr BA, Johann P, Wu G, Billups CA, Tatevossian RG, Dhanda SK, Srinivasan A, Broniscer A, Qaddoumi I, Vinitsky A, Armstrong GT, Bendel AE, Hassall T, Partap S, Fisher PG, Crawford JR, Chintagumpala M, Bouffet E, Gururangan S, Mostafavi R, Sanders RP, Klimo P Jr, Patay Z, Indelicato DJ, Nichols KE, Boop FA, Merchant TE, Kool M, Ellison DW, Gajjar A. Relevance of Molecular Groups in Children with Newly Diagnosed Atypical Teratoid Rhabdoid Tumor: Results from Prospective St. Jude Multi-institutional Trials. Clin Cancer Res. 2021 Mar 18. doi: 10.1158/1078-0432.CCR-20-4731. PMID: 33737307.
  3. Mahajan A, Stavinoha PL, Rongthong W, Brodin NP, McGovern SL, El Naqa I, Palmer JD, Vennarini S, Indelicato DJ, Aridgides P, Bowers DC, Kremer L, Ronckers C, Constine L, Avanzo M. Neurocognitive Effects and Necrosis in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys. 2021 Mar 9:S0360-3016(21)00127-9. doi: 10.1016/j.ijrobp.2020.11.073. PMID: 33810950.
  4. Looi WS, Indelicato DJ, Rutenberg MS. The Role of Radiation Therapy for Symptomatic Desmoid Tumors. Curr Treat Options Oncol. 2021 Mar 1;22(4):34. doi: 10.1007/s11864-021-00831-6.PMID: 33649873.
  5. Bryant CM, Hoppe BS. Promising long-term results with proton therapy for localized prostate cancer. Nat Rev Urol. 2021 Mar;18(3):137-138. doi: 10.1038/s41585-021-00429-5.PMID: 33505007. 
  6. De Leo AN, Holtzman AL, Ho MW, Morris CG, Rutenberg MS, Rotondo RL, Bates JE, Indelicato DJ, Rao D, Asa Hasan M, Mendenhall WM. Vision loss following high-dose proton-based radiotherapy for skull-base chordoma and chondrosarcoma. Radiother Oncol. 2021 Feb 19;158:125-130. doi: 10.1016/j.radonc.2021.02.012. PMID: 33610625
  7. Way AR, Fiester P, Holtzman A, Rao D. A Case of Carotid Body Tumor with Perineural Tumor Spread along the Superior Laryngeal Nerve. J Clin Imaging Sci. 2021 Feb 9;11:6. doi: 10.25259/JCIS_190_2020. eCollection 2021.PMID: 33654575.
  8. Indelicato DJ, Bates JE, Mailhot Vega RB, Rotondo RL, Hoppe BS, Morris CG, Looi WS, Sandler ES, Aldana PR, Bradley JA. Second tumor risk in children treated with proton therapy. Pediatr Blood Cancer. 2021 Feb 9:e28941. doi: 10.1002/pbc.28941. PMID: 33565257.
  9. Toussaint L, Indelicato DJ, Muren LP, Li Z, Lassen-Ramshad Y, Kirby K, Pedro C, Mikkelsen R, Di Pinto M, Høyer M, Stokkevåg CH. Response to: 'Comments on "Temporal lobe sparing radiotherapy with photons or protons for cognitive function preservation in pediatric craniopharyngioma" by Toussaint, et al.: Prior similar field arrangement work and a need for variable RBE Use'. Radiother Oncol. 2021 Feb 4:S0167-8140(21)06022-9. doi: 10.1016/j.radonc.2021.01.025. PMID: 33548282.
  10. Vapiwala N, Wong JK, Handorf E, Paly J, Grewal A, Tendulkar R, Godfrey D, Carpenter D, Mendenhall NP, Henderson RH, Stish BJ, Vargas C, Salama JK, Davis BJ, Horwitz EM. A Pooled Toxicity Analysis of Moderately Hypofractionated Proton Beam Therapy and Intensity Modulated Radiation Therapy in Early-Stage Prostate Cancer Patients. Int J Radiat Oncol Biol Phys. 2021 Feb 1:S0360-3016(21)00117-6. doi: 10.1016/j.ijrobp.2021.01.043. PMID: 33539968.
  11. Amdur RJ, Mendenhall NP, Mendenhall WM, Dagan R, Yeung AR, Okunieff PG. Journey to Diversity in a University Radiation Oncology Residency Program: The Role of Leadership and Target Goals. Am J Clin Oncol. 2021 Feb 1;44(2):45-48. doi: 10.1097/COC.0000000000000779. PMID: 33284238.
  12. Indelicato DJ, Ioakeim-Ioannidou M, Bradley JA, Mailhot-Vega RB, Morris CG, Tarbell NJ, Yock T, MacDonald SM. Proton Therapy for Pediatric Ependymoma: Mature Results From a Bicentric Study. Int J Radiat Oncol Biol Phys. 2021 Jan 27:S0360-3016(21)00087-0. doi: 10.1016/j.ijrobp.2021.01.027. PMID: 33508372.
  13. Lee NCJ, Eskander A, Miccio JA, Park HS, Shah C, Rutenberg M, Hosni A, Husain ZA. Evaluation of head and neck soft tissue sarcoma 8th edition pathologic staging system and proposal of a novel stage grouping system. Oral Oncol. 2021 Mar;114:105137. doi: 10.1016/j.oraloncology.2020.105137. Epub 2021 Jan 8. PMID: 33422859.
  14. Mailhot Vega RB, De La Mata D, Amendola B, Li B, Poitevin A, Sarria G, Sole S, Sher DJ, Hardenbergh P. Cross-Sectional International Survey to Determine the Educational Interests of Spanish-Speaking Latin American Radiation Oncologists. JCO Glob Oncol. 2021 Jan;7:29-34. doi: 10.1200/GO.20.00330. PMID: 33405959.
  15. Su Z, Henderson R, Nichols R, Bryant C, Hoppe B, Mendenhall W, Mendenhall N. A comparative study of prostate PTV margins for patients using hydrogel spacer or rectal balloon in proton therapy. Phys Med. 2021 Jan;81:47-51. doi: 10.1016/j.ejmp.2020.11.033. Epub 2020 Dec 27. PMID: 33378728.
  16. Liu APY, Wu G, Orr BA, Lin T, Ashford JM, Bass JK, Bowers DC, Hassall T, Fisher PG, Indelicato DJ, Klimo P Jr, Boop F, Conklin H, Onar-Thomas A, Merchant TE, Ellison DW, Gajjar A, Robinson GW. Outcome and molecular analysis of young children with choroid plexus carcinoma treated with non-myeloablative therapy: results from the SJYC07 trial. Neurooncol Adv. 2020 Dec 15;3(1):vdaa168. doi: 10.1093/noajnl/vdaa168. eCollection 2021 Jan-Dec. PMID: 33506206.
  17. Liu IC, Indelicato DJ, Bradley JA, Mailhot Vega RB, Sandler ES, Aldana PR. Simultaneous Diagnosis of Craniopharyngioma in 2 Brothers. J Pediatr Hematol Oncol. 2020 Dec 14. doi: 10.1097/MPH.0000000000002034. PMID: 33323881.
  18. Indelicato DJ, Rotondo RL, Mailhot Vega RB, Holtzman AL, Looi WS, Morris CG, Sandler ES, Aldana PR, Bradley JA. Local Control After Proton Therapy for Pediatric Chordoma. Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1406-1413. doi: 10.1016/j.ijrobp.2020.11.051.  Epub 2020 Nov 27. PMID: 33253819.
  19. Looi WS, Indelicato DJ, Mailhot Vega RB, Morris CG, Sandler E, Aldana PR, Bradley JA. Outcomes following limited-volume proton therapy for multifocal spinal myxopapillary ependymoma. Pediatr Blood Cancer. 2021 Mar;68(3):e28820. doi: 10.1002/pbc.28820. Epub 2020 Nov 23. PMID: 33226179.
  20. Mailhot Vega RB. Broadening the Tent with Intentional Spaces. Int J Radiat Oncol Biol Phys. 2020 Nov 15;108(4):1118-1119. doi: 10.1016/j.ijrobp.2020.05.058.PMID: 33069344.
  21. Kharod SM, Nichols RC, Henderson RH, Morris CG, Pham DC, Seeram VK, Jones LM,  Antonio-Miranda M, Siragusa DA, Li Z, Flampouri S, Hoppe BS. Image-Guided Hypofractionated Proton Therapy in Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Study. Int J Part Ther. 2020 Nov 6;7(2):1-10. doi: 10.14338/IJPT-20-00013.1. eCollection 2020 Fall. PMID: 33274252.
  22. Mendenhall WM, Holtzman AL, Dagan R, Bryant CM, Hitchcock KE, Amdur RJ, Fernandes RP. Current Role of Radiotherapy in the Management of Oral Cavity Squamous Cell Carcinoma. Craniomaxillofac Trauma Reconstr. 2021 Mar;14(1):79-83. doi: 10.1177/1943387520971418. Epub 2020 Nov 3. PMID: 33613841.
  23. Otterlei OM, Indelicato DJ, Toussaint L, Ytre-Hauge KS, Pilskog S, Fjaera LF, Rørvik E, Pettersen HES, Muren LP, Lassen-Ramshad Y, Di Pinto M, Stokkevåg CH. Variation in relative biological effectiveness for cognitive structures in proton therapy of pediatric brain tumors. Acta Oncol. 2021 Feb;60(2):267-274. doi: 10.1080/0284186X.2020.1840626. Epub 2020 Nov 2. PMID: 33131367.
  24. De Leo AN, Bates JE, Lockney NA, Mendenhall NP, Shaikh ME, Morris CG, Hoppe BS.Radiotherapy in Early-stage Gastric MALT: Improved Survival Without Increased Cardiac Death. Am J Clin Oncol. 2020 Nov;43(11):770-775. doi: 10.1097/COC.0000000000000747. PMID: 32841963.
  25. Bergom C, Rubenstein J, Wilson JF, Welsh A, Ibrahim EH, Prior P, Schottstaedt AM, Eastwood D, Zhang MJ, Currey A, Puckett L, Strande JL, Bradley JA, White J. A Pilot Study of Cardiac MRI in Breast Cancer Survivors After Cardiotoxic Chemotherapy and Three-Dimensional Conformal Radiotherapy. Front Oncol. 2020 Oct 16;10:506739. doi: 10.3389/fonc.2020.506739. eCollection 2020. PMID: 33178571.
  26. Liu C, Zheng D, Bradley JA, Mailhot Vega RB, Zhang Y, Indelicato DJ, Mendenhall N, Liang X. Incorporation of the LETd-weighted biological dose in the evaluation of breast intensity-modulated proton therapy plans. Acta Oncol. 2021 Feb;60(2):252-259. doi: 10.1080/0284186X.2020.1834141. Epub 2020 Oct 16. PMID: 33063569.
  27. Fjæra LF, Indelicato DJ, Stokkevåg CH, Muren LP, Hsi WC, Ytre-Hauge KS. Implementation of a double scattering nozzle for Monte Carlo recalculation of proton plans with variable relative biological effectiveness. Phys Med Biol. 2020 Oct 14. doi: 10.1088/1361-6560/abc12d. PMID: 33053524. 
  28. Uh J, Merchant TE, Conklin HM, Ismael Y, Li Y, Han Y, Sabin ND, Babajani-Feremi A, Indelicato DJ, Hua CH. Diffusion Tensor Imaging-Based Analysis of Baseline Neurocognitive Function and Posttreatment White Matter Changes in Pediatric Patients With Craniopharyngioma Treated With Surgery and Proton Therapy. Int J Radiat Oncol Biol Phys. 2021 Feb 1;109(2):515-526. doi: 10.1016/j.ijrobp.2020.08.060. Epub 2020 Sep 6. PMID: 32898610.
  29. Fjæra LF, Indelicato DJ, Ytre-Hauge KS, Muren LP, Lassen-Ramshad Y, Toussaint L, Dahl O, Stokkevåg CH. Spatial Agreement of Brainstem Dose Distributions Depending on Biological Model in Proton Therapy for Pediatric Brain Tumors. Adv Radiat Oncol. 2020 Aug 28;6(1):100551. doi: 10.1016/j.adro.2020.08.008. eCollection 2021 Jan-Feb. PMID: 33490724.
  30. Tseng YD, Hoppe BS, Dedeckova K, Patel CG, Hill-Kayser CE, Miller DM, Maity A, Mendenhall NP, Mailhot Vega RB, Yock TI, Baliga S, Hess CB, Winkfield KM, Mohindra P, Rosen LR, Tsai H, Chang J, Hartsell WF, Plastaras JP. Risk of Pneumonitis and Outcomes After Mediastinal Proton Therapy for Relapsed/Refractory Lymphoma: A PTCOG and PCG Collaboration. Int J Radiat Oncol Biol Phys. 2021 Jan 1;109(1):220-230. doi: 10.1016/j.ijrobp.2020.08.055. Epub 2020 Aug 28. PMID: 32866566.
  31. Liu C, Zheng D, Bradley JA, Vega RBM, Li Z, Mendenhall NP, Liang X. Patient-specific quality assurance and plan dose errors on breast intensity-modulated proton therapy. Phys Med. 2020 Sep;77:84-91. doi: 10.1016/j.ejmp.2020.08.006. Epub 2020 Aug 13. PMID: 32799050.
  32. Eaton BR, Schwarz R, Vatner R, Yeh B, Claude L, Indelicato DJ, Laack N. Osteosarcoma. Pediatr Blood Cancer. 2021 May;68 Suppl 2:e28352. doi: 10.1002/pbc.28352. Epub 2020 Aug 11. PMID: 32779875.
  33. Bates JE, Indelicato DJ, Morris CG, Rotondo RL, Bradley JA. Visual decline in pediatric survivors of brain tumors following radiotherapy. Acta Oncol. 2020 Oct;59(10):1257-1262. doi: 10.1080/0284186X.2020.1803500. Epub 2020 Aug 7. PMID: 32762400.
  34. Klawinski D, Indelicato DJ, Hossain J, Sandler E. Surveillance imaging in pediatric ependymoma. Pediatr Blood Cancer. 2020 Nov;67(11):e28622. doi: 10.1002/pbc.28622. Epub 2020 Aug 3. PMID: 32743915.
  35. Beaty BT, Moon DH, Shen CJ, Amdur RJ, Weiss J, Grilley-Olson J, Patel S, Zanation A, Hackman TG, Thorp B, Blumberg JM, Patel SN, Weissler MC, Yarbrough WG, Sheets NC, Parker JS, Neil Hayes D, Weck KE, Ramkissoon LA, Mendenhall WM, Dagan R, Tan X, Gupta GP, Chera BS. PIK3CA Mutation in HPV-Associated OPSCC Patients Receiving Deintensified Chemoradiation. J Natl Cancer Inst. 2020 Aug 1;112(8):855-858. doi: 10.1093/jnci/djz224. PMID: 31747025.
  36. Liu IC, Giap F, Mailhot-Vega RB, Bradley JA, Mendenhall NP, Okunieff P, Lu L, Jantz MA, Daily K, Spiguel L, Lockney NA. Concomitant Radiation Recall Dermatitis and Organizing Pneumonia following Breast Radiotherapy: A Case Report. Case Rep Oncol. 2020 Jul 29;13(2):875-882. doi: 10.1159/000508493. eCollection 2020 May-Aug. PMID: 32884534.
  37. Leeman R, Pinkney K, Bradley JA, Ruiz R, DuBois SG, French C, Trucco M. NUT Carcinoma Without Upfront Surgical Resection: A Case Report. J Pediatr Hematol Oncol. 2020 Jun 16. doi: 10.1097/MPH.0000000000001865. PMID: 32555033.
  38. Suneja G, Mattes MD, Mailhot Vega RB, Escorcia FE, Lawton C, Greenberger J, Kesarwala AH, Spektor A, Vikram B, Deville C, Siker M. Pathways for Recruiting and Retaining Women and Underrepresented Minority Clinicians and Physician Scientists Into the Radiation Oncology Workforce: A Summary of the 2019 ASTRO/NCI Diversity Symposium Session at the ASTRO Annual Meeting.  Adv Radiat Oncol. 2020 May 21;5(5):798-803. doi: 10.1016/j.adro.2020.05.003. eCollection 2020 Sep-Oct. PMID: 33083641.
  39. Kharod SM, Nichols RC, Henderson RH, Morris CG, Pham DC, Seeram VK, Jones LM, Antonio-Miranda M, Huh S, Li Z, Hoppe BS. Image-guided hypofractionated double-scattering proton therapy in the management of centrally-located early-stage non-small cell lung cancer. Acta Oncol. 2020 Oct;59(10):1164-1170. doi: 10.1080/0284186X.2020.1759821. Epub 2020 May 12. PMID: 32394776.
  40. Uezono H, Indelicato DJ, Rotondo RL, Mailhot Vega RB, Bradfield SM, Morris CG, Bradley JA. Treatment Outcomes After Proton Therapy for Ewing Sarcoma of the Pelvis. Int J Radiat Oncol Biol Phys. 2020 Aug 1;107(5):974-981. doi: 10.1016/j.ijrobp.2020.04.043. Epub 2020 May 8. PMID: 32437922 Clinical Trial.
  41. Su Z, Indelicato DJ, Mailhot RB, Bradley JA. Impact of different treatment techniques for pediatric Ewing sarcoma of the chest wall: IMRT, 3DCPT, and IMPT with/without beam aperture. J Appl Clin Med Phys. 2020 Jun;21(6):100-107. doi: 10.1002/acm2.12870. Epub 2020 Apr 8.PMID: 32268008.
  42. Hill-Kayser CE, Indelicato DJ, Ermoian R, Salerno K, Breneman J. Pediatric Central Nervous System Germinoma: What Can We Understand From a Worldwide Effort to Maximize Cure and Minimize Risk? Int J Radiat Oncol Biol Phys. 2020 Jun 1;107(2):227-231. doi: 10.1016/j.ijrobp.2020.03.039. Epub 2020 Apr 7. PMID: 32275995 Review.
  43. Hoppe BS, Nichols RC, Flampouri S, Li Z, Morris CG, Pham DC, Mohindra P, Hartsell W, Mohammed N, Chon BH, Simone CB 2nd. Hypofractionated Proton Therapy with Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Trial from the University of Florida and Proton Collaborative Group. Int J Radiat Oncol Biol Phys. 2020 Jul 1;107(3):455-461. doi: 10.1016/j.ijrobp.2020.03.015. Epub 2020 Apr 3. PMID: 32251754 Clinical Trial.
  44. Hoppe BS, Mailhot Vega RB, Mendenhall NP, Sandler ES, Slayton WB, Katzenstein H, Joyce MJ, Li Z, Flampouri S. Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma. Int J Part Ther. 2020 Spring;6(4):11-16. doi: 10.14338/IJPT-19-00077.1. Epub 2020 Apr 27. PMID: 32582815.
  45. Bates JE, Parikh RR, Mendenhall NP, Morris CG, Hoppe RT, Constine LS, Hoppe BS. Long-Term Outcomes in 10-Year Survivors of Early-Stage Hodgkin Lymphoma. Int J Radiat Oncol Biol Phys. 2020 Jul 1;107(3):522-529. doi: 10.1016/j.ijrobp.2020.02.642. Epub 2020 Mar 12. PMID: 32173399.
  46. Shih HA, Rengan R, Apisarnthanarax S, Cheng CW, Daartz J, DeLaney TF, Hartsell WF, Indelicato DJ, Keole SR, Rosenthal S, Hartford AC. ACR-ASTRO Practice Parameter for the Performance of Proton Beam Radiation Therapy. Am J Clin Oncol. 2020 Mar;43(3):149-159. doi: 10.1097/COC.0000000000000672. PMID: 32028342.
  47. Liang X, Mailhot Vega RB, Li Z, Zheng D, Mendenhall N, Bradley JA. Dosimetric consequences of image guidance techniques on robust optimized intensity-modulated proton therapy for treatment of breast Cancer. Radiat Oncol. 2020 Feb 27;15(1):47. doi: 10.1186/s13014-020-01495-6. PMID: 32103762.
  48. Mailhot Vega RB, Hoppe BS. A positive approach: advances in proton therapy for the treatment of mediastinal lymphoma. Expert Rev Hematol. 2020 Mar;13(3):197-200. doi: 10.1080/17474086.2020.1713745. Epub 2020 Feb 24. PMID: 31976780.
  49. Rutenberg MS, Rotondo RL, Rao D, Holtzman AL, Indelicato DJ, Huh S, Morris CG, Mendenhall WM. Clinical outcomes following proton therapy for adult craniopharyngioma: a single-institution cohort study. J Neurooncol. 2020 Apr;147(2):387-395. doi: 10.1007/s11060-020-03432-9. Epub 2020 Feb 21. PMID: 32086697 Clinical Trial.
  50. Bradley JA, Indelicato DJ, Uezono H, Morris CG, Sandler E, de Soto H, Mailhot Vega RB, Rotondo R. Patterns of Failure in Parameningeal Alveolar Rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2020 Jun 1;107(2):325-333. doi: 10.1016/j.ijrobp.2020.01.035. Epub 2020 Feb 7. PMID: 32044412 Clinical Trial.
  51. Rutenberg MS, Nichols RC. Proton beam radiotherapy for pancreas cancer. J Gastrointest Oncol. 2020 Feb;11(1):166-175. doi: 10.21037/jgo.2019.03.02. PMID: 32175120 Review.
  52. Bradley JA, Bellon JR. Quality of Life and Limb: Reducing Lymphedema Risk After Breast Cancer Therapy. Int J Radiat Oncol Biol Phys. 2020 Feb 1;106(2):225-229. doi: 10.1016/j.ijrobp.2019.10.033. PMID: 31928634 Review.
  53. Liu APY, Gudenas B, Lin T, Orr BA, Klimo P Jr, Kumar R, Bouffet E, Gururangan S, Crawford JR, Kellie SJ, Chintagumpala M, Fisher MJ, Bowers DC, Hassall T, Indelicato DJ, Onar-Thomas A, Ellison DW, Boop FA, Merchant TE, Robinson GW, Northcott PA, Gajjar A. Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials. Acta Neuropathol. 2020 Feb;139(2):273-275. doi: 10.1007/s00401-019-02115-8. PMID: 31865440.
  54. Indelicato DJ, Rotondo RL, Krasin MJ, Mailhot Vega RB, Uezono H, Bradfield S, Agarwal V, Morris CG, Bradley JA. Outcomes Following Proton Therapy for Group III Pelvic Rhabdomyosarcoma.  Int J Radiat Oncol Biol Phys. 2020 Apr 1;106(5):968-976. doi: 10.1016/j.ijrobp.2019.12.036. Epub 2020 Jan 25. PMID: 31987977 Clinical Trial.
  55. Mendenhall WM, Holtzman AL, Dagan R, Bryant CM, Hitchock KE, Amdur RJ. In Regardnto Sher et al. Int J Radiat Oncol Biol Phys. 2020 Jan 1;106(1):220-221. doi: 10.1016/j.ijrobp.2019.09.042. PMID: 31836086. 
  56. Holtzman AL, Mendenhall WM. High-dose conformal proton therapy for clinical perineural invasion in cutaneous head and neck cancer. Oral Oncol. 2020 Jan;100:104486. 
    doi: 10.1016/j.oraloncology.2019.104486. Epub 2019 Dec 5. PMID: 31812007 Review.
  57. Liu APY, Gudenas B, Lin T, Orr BA, Klimo P Jr, Kumar R, Bouffet E, Gururangan S, Crawford JR, Kellie SJ, Chintagumpala M, Fisher MJ, Bowers DC, Hassall T, Indelicato DJ, Onar-Thomas A, Ellison DW, Boop FA, Merchant TE, Robinson GW, Northcott PA, Gajjar A. Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trials. Acta Neuropathol. 2020 Feb;139(2):259-271. Doi: 10.1007/s00401-019-02106-9. Epub 2019 Dec 4.PMID: 31802236 Clinical Trial.
  58. Kharod SM, Indelicato DJ, Rotondo RL, Mailhot Vega RB, Uezono H, Morris CG, Bradfield S, Sandler ES, Bradley JA. Outcomes following proton therapy for Ewing sarcoma of the cranium and skull base. Pediatr Blood Cancer. 2020 Feb;67(2):e28080. doi: 10.1002/pbc.28080. Epub 2019 Nov 17. PMID: 31736243. 
  59. Lawell MP, Indelicato DJ, Paulino AC, Hartsell W, Laack NN, Ermoian RP, Perentesis JP, Vatner R, Perkins S, Mangona VS, Hill-Kayser CE, Wolden SL, Kwok Y, Chang JH, Wilkinson JB, MacEwan I, Chang AL, Eaton BR, Ladra MM, Gallotto SL, Weyman EA, Bajaj BVM, Baliga S, Yeap BY, Berrington de Gonzalez A, Yock TI. An open invitation to join the Pediatric Proton/Photon Consortium Registry to standardize data collection in pediatric radiation oncology. Br J Radiol. 2020 Mar;93(1107):20190673. doi: 10.1259/bjr.20190673. Epub 2019 Nov 1. PMID: 31600082.
  60. Khullar K, Rivera-Núñez Z, Jhawar SR, Drachtman R, Cole PD, Hoppe BS, Parikh RR. Pediatric hodgkin lymphoma: disparities in survival by race. Leuk Lymphoma. 2020 Mar;61(3):546-556. doi: 10.1080/10428194.2019.1680841. Epub 2019 Oct 23. PMID: 31640446.
  61. Hol MLF, Indelicato DJ, Rotondo RL, Mailhot Vega RB, Uezono H, Lockney NA, Sandler E, Bradley JA. Dose-Effect Analysis of Early Changes in Orbital Bone Morphology After Radiation Therapy for Rhabdomyosarcoma. Pract Radiat Oncol. 2020 Jan-Feb;10(1):53-58. doi: 10.1016/j.prro.2019.10.002. Epub 2019 Oct 16. PMID: 31629089.
  62. Liang X, Bradley JA, Mailhot Vega RB, Rutenberg M, Zheng D, Getman N, Norton KW, Mendenhall N, Li Z. Using Robust Optimization for Skin Flashing in Intensity Modulated Radiation Therapy for Breast Cancer Treatment: A Feasibility Study. Pract Radiat Oncol. 2020 Jan-Feb;10(1):59-69. doi: 10.1016/j.prro.2019.09.017. Epub 2019 Oct 15. PMID: 31627030.
  63. Rao D, Fiester P, Patel J, Rutenberg M, Holtzman A, Dagan R, Rotondo RL, Sandhu SJS.Multidisciplinary Imaging Review Conference Improves Neuro-oncology Radiation Treatment Planning and Follow-up. Cureus. 2019 Oct 10;11(10):e5882. doi: 10.7759/cureus.5882. PMID: 31772852.
  64. Hoppe BS, Bates JE, Mendenhall NP, Morris CG, Louis D, Ho MW, Hoppe RT, Shaikh M, Li Z, Flampouri S. The Meaningless Meaning of Mean Heart Dose in Mediastinal Lymphoma in the Modern Radiation Therapy Era. Pract Radiat Oncol. 2020 May-Jun;10(3):e147-e154. doi: 10.1016/j.prro.2019.09.015. Epub 2019 Oct 2.PMID: 31586483.
  65. Wieland J, Hoppe BS, Rausch-Osian SM, King JC, Sierra A, Hiemenz JW, Bradley J, Pham DC, Jones LM, Yeung AR, Hopper K, Mendenhall NP, Hitchcock KE. Survivor and Caregiver Expectations and Preferences Regarding Lung Cancer Treatment. Int J Part Ther. 2019 Fall;6(2):42-49. doi: 10.14338/IJPT-19-00072.1. Epub 2019 Nov 26. PMID: 31998820.
  66. Mendenhall WM, Smith S, Morris CG, Bradley JA, Mailhot Vega RB, McIntyre K, Klein SL, Mendenhall NP. Insurance Coverage for Adjuvant Proton Therapy in the Definitive Treatment of Breast Cancer. Int J Part Ther. 2019 Fall;6(2):26-30. doi: 10.14338/IJPT-19-00070.1. Epub 2019 Oct 11. PMID: 31998818. 
  67. Indelicato DJ, Rotondo RL, Mailhot Vega RB, Uezono H, Bradfield S, Agarwal V, Hol ML, Bradley JA. 45 GyRBE for group III orbital embryonal rhabdomyosarcoma. Acta Oncol. 2019 Oct;58(10):1404-1409. doi: 10.1080/0284186X.2019.1627412. Epub 2019 Sep 18. PMID: 31530120.
  68. Uezono H, Indelicato DJ, Rotondo RL, Sandler ES, Katzenstein HM, Dagan R, Mendenhall WM, Mailhot Vega R, Brennan BM, Bradley JA. Proton therapy following induction chemotherapy for pediatric and adolescent nasopharyngeal carcinoma. Pediatr Blood Cancer. 2019 Dec;66(12):e27990. doi: 10.1002/pbc.27990. Epub 2019 Sep 16. PMID: 31524334.
  69. Mascarenhas L, Chi YY, Hingorani P, Anderson JR, Lyden ER, Rodeberg DA, Indelicato DJ, Kao SC, Dasgupta R, Spunt SL, Meyer WH, Hawkins DS. Randomized Phase II Trial of Bevacizumab or Temsirolimus in Combination With Chemotherapy for First Relapse Rhabdomyosarcoma: A Report From the Children's Oncology Group. J Clin Oncol. 2019 Nov 1;37(31):2866-2874. doi: 10.1200/JCO.19.00576. Epub 2019 Sep 12. PMID: 31513481. Clinical Trial.
  70. Bates JE, Flampouri S, Hoppe RT, Li Z, Mendenhall NP, Hoppe BS. Tomayto, tomahto: prescription dose and mean heart dose in evaluating the cardiac impact of involved-field radiation therapy for Hodgkin lymphoma survivors. Acta Oncol. 2019 Dec;58(12):1783-1785. doi: 10.1080/0284186X.2019.1657943. Epub 2019 Sep 6. PMID: 31742489.
  71. Toussaint L, Indelicato DJ, Muren LP, Li Z, Lassen-Ramshad Y, Kirby K, Pedro C, Mikkelsen R, Di Pinto M, Høyer M, Stokkevåg CH. Temporal lobe sparing radiotherapy with photons or protons for cognitive function preservation in paediatric craniopharyngioma. Radiother Oncol. 2020 Jan;142:140-146. doi: 10.1016/j.radonc.2019.08.002. Epub 2019 Aug 28. PMID: 31472997.
  72. Hibbitts E, Chi YY, Hawkins DS, Barr FG, Bradley JA, Dasgupta R, Meyer WH, Rodeberg DA, Rudzinski ER, Spunt SL, Skapek SX, Wolden SL, Arndt CAS. Refinement of risk stratification for childhood rhabdomyosarcoma using FOXO1 fusion status in addition to established clinical outcome predictors: A report from the Children's Oncology Group. Cancer Med. 2019 Oct;8(14):6437-6448. doi: 10.1002/cam4.2504. Epub 2019 Aug 27. PMID: 31456361.
  73. Ludmir EB, Mahajan A, Ahern V, Ajithkumar T, Alapetite C, Bernier-Chastagner V, Bindra RS, Bishop AJ, Bolle S, Brown PD, Carrie C, Chalmers AJ, Chang EL, Chung C, Dieckmann K, Esiashvili N, Gandola L, Ghia AJ, Gondi V, Grosshans DR, Harrabi SB, Horan G, Indelicato DJ, Jalali R, Janssens GO, Krause M, Laack NN, Laperriere N, Laprie A, Li J, Marcus KJ, McGovern SL, Merchant TE, Merrell KW, Padovani L, Parkes J, Paulino AC, Schwarz R, Shih HA, Souhami L, Sulman EP, Taylor RE, Thorp N, Timmermann B, Wheeler G, Wolden SL, Woodhouse KD, Yeboa DN, Yock TI, Kortmann RD, McAleer MF. Assembling the brain trust: the multidisciplinary imperative in neuro-oncology. Nat Rev Clin Oncol. 2019 Aug;16(8):521-522. doi: 10.1038/s41571-019-0235-z. PMID: 31150024.
  74. Stokkevåg CH, Indelicato DJ, Herfarth K, Magelssen H, Evensen ME, Ugland M, Nordberg T, Nystad TA, Hægeland C, Alsaker MD, Ulven K, Dale JE, Engeseth GM, Boer CG, Toussaint L, Kornerup JS, Pettersen HES, Brydøy M, Brandal P, Muren LP. Normal tissue complication probability models in plan evaluation of children with brain tumors referred to proton therapy. Acta Oncol. 2019 Oct;58(10):1416-1422. doi: 10.1080/0284186X.2019.1643496. Epub 2019 Jul 31. PMID: 31364899.
  75. Nichols RC, Rutenberg M. Optimizing neoadjuvant radiotherapy for resectable and borderline resectable pancreatic cancer using protons. World J Gastrointest Surg. 2019 Jul 27;11(7):303-307. doi: 10.4240/wjgs.v11.i7.303. PMID: 31602289.
  76. Holtzman AL, Stahl JM, Zhu S, Morris CG, Hoppe BS, Kirwan JE, Mendenhall NP. Does the Incidence of Treatment-Related Toxicity Plateau After Radiation Therapy: The Long-Term Impact of Integral Dose in Hodgkin's Lymphoma Survivors. Adv Radiat Oncol. 2019 Jul 23;4(4):699-705. doi: 10.1016/j.adro.2019.07.010. eCollection 2019 Oct-Dec. PMID: 31673663.
  77. Toussaint L, Indelicato DJ, Holgersen KS, Petersen JBB, Stokkevåg CH, Lassen-Ramshad Y, Casares-Magaz O, Vestergaard A, Muren LP. Towards proton arc therapy: physical and biologically equivalent doses with increasing number of beams in pediatric brain irradiation. Acta Oncol. 2019 Oct;58(10):1451-1456. doi: 10.1080/0284186X.2019.1639823. Epub 2019 Jul 15. PMID: 31303090.
  78. Toussaint L, Indelicato DJ, Stokkevåg CH, Lassen-Ramshad Y, Pedro C, Mikkelsen R, Di Pinto M, Li Z, Flampouri S, Vestergaard A, Petersen JBB, Schrøder H, Høyer M, Muren LP. Radiation doses to brain substructures associated with cognition in radiotherapy of pediatric brain tumors. Acta Oncol. 2019 Oct;58(10):1457-1462. doi: 10.1080/0284186X.2019.1629014. Epub 2019 Jul 4. PMID: 31271084.
  79. Bates JE, Morris CG, Milano MT, Yeung AR, Hoppe BS. Immunotherapy with hypofractionated radiotherapy in metastatic non-small cell lung cancer: An analysis of the National Cancer Database. Radiother Oncol. 2019 Sep;138:75-79. doi: 10.1016/j.radonc.2019.06.004. Epub 2019 Jun 25. PMID: 31252297.
  80. Lockney NA, Zhang M, Morris CG, Nichols RC, Okunieff P, Swarts S, Zhang Z, Zhang B, Zhang A, Hoppe BS. Radiation-induced tumor immunity in patients with non-small cell lung cancer. Thorac Cancer. 2019 Jul;10(7):1605-1611. doi: 10.1111/1759-7714.13122. Epub 2019 Jun 22. PMID: 31228354.
  81. Everett AS, Hoppe BS, Louis D, McDonald AM, Morris CG, Mendenhall NP, Li Z, Flampouri S. Comparison of Techniques for Involved-Site Radiation Therapy in Patients With Lower Mediastinal Lymphoma. Pract Radiat Oncol. 2019 Nov;9(6):426-434. doi: 10.1016/j.prro.2019.05.009. Epub 2019 May 22. PMID: 31128302 Review.
  82. Liang X, Bradley JA, Zheng D, Rutenberg M, Mailhot Vega R, Mendenhall N, Li Z. The impact of dose algorithms on tumor control probability in intensity-modulated proton therapy for breast cancer. Phys Med. 2019 May;61:52-57. doi: 10.1016/j.ejmp.2019.04.011. Epub 2019 May 3. PMID: 31151579.
  83. Bechtel AS, Indelicato DJ, Sandler E. Enteral Nutrition in Pediatric High-risk Head and Neck Cancer Patients Receiving Proton Therapy: Identifying Risk Factors and Quality of Life Concerns to Optimize Care. J Pediatr Hematol Oncol. 2019 May;41(4):e247-e253. doi: 10.1097/MPH.0000000000001364. PMID: 31026252.
  84. Jhawar SR, Rivera-Núñez Z, Drachtman R, Cole PD, Hoppe BS, Parikh RR. Association of Combined Modality Therapy vs Chemotherapy Alone With Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma. JAMA Oncol. 2019 May 1;5(5):689-695. doi: 10.1001/jamaoncol.2018.5911. PMID: 30605220.
  85. Bates JE, Klassen C, Ozdemir S, Flampouri S, Percy R, Mendenhall NP, Hoppe BS. Cardiac MRI for Detecting Early Cardiac Toxicity after Proton Therapy for Hodgkin Lymphoma. Int J Part Ther. 2019 Spring;5(4):41-44. doi: 10.14338/IJPT-19-00052.1. Epub 2019 May 7. PMID: 31773040.
  86. Dagan R, Bryant CM, Mendenhall WM, Amdur RJ, Morris CG, Lanza DC, Dziegielewski PT, Justice JM, Lobo BC, Silver NL, Fernandes R, Bunnell A, Guthrie T, Gopalan PK, Rahman M, Tavanaiepour D. Isolated leptomeningeal progression from sinonasal carcinomas: Implications for staging workup and treatment. Head Neck. 2019 Aug;41(8):2647-2654. doi: 10.1002/hed.25741. Epub 2019 Mar 25. PMID: 30908735.
  87. Mailhot Vega RB, Lockney NA, MacDonald SM, Mendenhall NP, Bradley JA. In Regard to Stecklein et al. Int J Radiat Oncol Biol Phys. 2019 Apr 1;103(5):1280-1281. doi: 10.1016/j.ijrobp.2018.11.061. Epub 2019 Mar 13. PMID: 30900561.
  88. Bates JE, Howell RM, Liu Q, Yasui Y, Mulrooney DA, Dhakal S, Smith SA, Leisenring WM, Indelicato DJ, Gibson TM, Armstrong GT, Oeffinger KC, Constine LS. Therapy-Related Cardiac Risk in Childhood Cancer Survivors: An Analysis of the Childhood Cancer Survivor Study. J Clin Oncol. 2019 May 1;37(13):1090-1101. doi: 10.1200/JCO.18.01764. Epub 2019 Mar 12. PMID: 30860946. 
  89. Holtzman AL, Rotondo RL, Rutenberg MS, Indelicato DJ, Mercado CE, Rao D, Tavanaiepour D, Morris CG, Louis D, Flampouri S, Mendenhall WM. Proton therapy for skull-base chondrosarcoma, a single-institution outcomes study. J Neurooncol. 2019 May;142(3):557-563. doi: 10.1007/s11060-019-03129-8. Epub 2019 Mar 2. PMID: 30827010 Clinical Trial.
  90. Cooper BT, Bradley JA. Chemotherapy to Spare Cognition. Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):544-545. doi: 10.1016/j.ijrobp.2018.10.040. PMID: 30722967.
  91. Holtzman AL, Bryant CM, Mendenhall NP, Mendenhall WM, Nichols RC, Henderson RH, Figura N, Morris CG, Williams CR, Li Z, Hoppe BS. Patient-Reported Sexual Survivorship Following High-Dose Image-Guided Proton Therapy for Prostate Cancer. Radiother Oncol. 2019 May;134:204-210. doi: 10.1016/j.radonc.2019.01.029. Epub 2019 Feb 27. PMID: 31005217.
  92. Badiyan SN, Rutenberg MS, Hoppe BS, Mohindra P, Larson G, Hartsell WF, Tsai H, Zeng J, Rengan R, Glass E, Katz S, Vargas C, Feigenberg SJ, Simone CB 2nd. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies. Pract Radiat Oncol. 2019 Jul-Aug;9(4):280-288. doi: 10.1016/j.prro.2019.02.008. Epub 2019 Feb 23. PMID: 30802618.
  93. Mercado CE, Hartsell WF, Simone CB 2nd, Tsai HK, Vargas CE, Zhu HJ, Henderson RH, Zeng J, Larson GL, Hoppe BS. Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registries. Acta Oncol. 2019 Jul;58(7):1036-1040. doi: 10.1080/0284186X.2019.1575981. Epub 2019 Feb 20. PMID: 30784340.
  94. Su Z, Li Z, Henderson R, Hoppe B, Nichols RC, Bryant C, Mendenhall W, Mendenhall N. PTV margin analysis for prostate patients treated with initial pelvic nodal IMRT and prostate proton boost. Phys Med Biol. 2019 Feb 8;64(4):04NT04. doi: 10.1088/1361-6560/aafd75. PMID: 30630135.
  95. Slopsema RL, Mamalui M, Bolling J, Flampouri S, Yeung D, Li Z, Rutenberg MS, Dagan R. Can CT imaging improve targeting accuracy in clip-based proton therapy of ocular melanoma? Phys Med Biol. 2019 Jan 24;64(3):035010. doi: 10.1088/1361-6560/aaf9c9. PMID: 30566923.
  96. Indelicato DJ, Rotondo RL, Uezono H, Sandler ES, Aldana PR, Ranalli NJ, Beier AD, Morris CG, Bradley JA. Outcomes Following Proton Therapy for Pediatric Low-Grade Glioma.  Int J Radiat Oncol Biol Phys. 2019 May 1;104(1):149-156. doi: 10.1016/j.ijrobp.2019.01.078. Epub 2019 Jan 23. PMID: 30684665.
  97. Zhu HJ, Nichols RC, Henderson RH, Morris CG, Flampouri S, Pham DC, Klassen CL, Seeram V, Cury JD, Jones L, McGee L, Hoppe BS. Impact of unfavorable factors on outcomes among inoperable stage II-IV Nonsmall cell lung cancer patients treated with proton therapy. Acta Oncol. 2019 Mar;58(3):313-319. doi: 10.1080/0284186X.2018.1546060. Epub 2019 Jan 18. PMID: 30656994 Clinical Trial.
  98. O'steen L, Bellardini J, Cury J, Jones L, Seeram VK, Mendenhall NP, Hoppe BS. Pulmonary Function after Proton Therapy for Hodgkin Lymphoma.  Int J Part Ther. 2019 Winter;5(3):1-4. doi: 10.14338/IJPT-18-00040.1. Epub 2019 Mar 21. PMID: 31788502.
  99. Nichols RC, Morris CG, Bryant C, Hoppe BS, Henderson RH, Mendenhall WM, Li Z, Costa JA, Williams CR, Mendenhall NP. Serum Testosterone 60 Months after Passive-Scatter Proton Therapy for Localized Prostate Cancer. Cancer Invest. 2019;37(2):85-89. doi: 10.1080/07357907.2019.1565766. Epub 2019 Mar 5. PMID: 30836776.
  100. Mercado CE, Holtzman AL, Rotondo R, Rutenberg MS, Mendenhall WM. Proton therapy for skull base tumors: A review of clinical outcomes for chordomas and chondrosarcomas. Head Neck. 2019 Feb;41(2):536-541. doi: 10.1002/hed.25479. Epub 2018 Dec 7. PMID: 30537295 Review.
  101. Mailhot Vega RB Jr, Barbee D, Talcott W, Duckworth T, Shah BA, Ishaq OF, Small C, Yeung AR, Perez CA, Schiff PB, Ginsburg O, Small W, Abdel-Wahab M, Bardales GS, Harkenrider M. Cost in perspective: direct assessment of American market acceptability of Co-60 in gynecologic high-dose-rate brachytherapy and contrast with experience abroad. J Contemp Brachytherapy. 2018 Dec;10(6):503-509. doi: 10.5114/jcb.2018.79928. Epub 2018 Dec 28. PMID: 30662472.
  102. Mendenhall WM, Sarto G, Bryant CM, Morris CG, Williams CR, Costa JA, Bandyk M, Hoppe BS, Henderson RH, Nichols RC, Mendenhall NP. Rectal Culture and Sensitivity Analysis for Reducing Sepsis Risk After Fiducial Marker Placement. Am J Clin Oncol. 2018 Dec;41(12):1243-1245. doi: 10.1097/COC.0000000000000454. PMID: 29727310.
  103. Liang X, Li Z, Zheng D, Bradley JA, Rutenberg M, Mendenhall N. A comprehensive dosimetric study of Monte Carlo and pencil-beam algorithms on intensity-modulated proton therapy for breast cancer. J Appl Clin Med Phys. 2019 Jan;20(1):128-136. doi: 10.1002/acm2.12497. Epub 2018 Nov 28. PMID: 30488548.
  104. Journy N, Indelicato DJ, Withrow DR, Akimoto T, Alapetite C, Araya M, Chang A, Chang JH, Chon B, Confer ME, Demizu Y, Dendale R, Doyen J, Ermoian R, Gurtner K, Hill-Kayser C, Iwata H, Kim JY, Kwok Y, Laack NN, Lee C, Lim DH, Loredo L, Mangona VS, Mansur DB, Murakami M, Murayama S, Ogino T, Ondrová B, Parikh RR, Paulino AC, Perkins S, Ramakrishna NR, Richter R, Rombi B, Shibata S, Shimizu S, Timmermann B, Vern-Gross T, Wang CJ, Weber DC, Wilkinson JB, Witt Nyström P, Yock TI, Kleinerman RA, Berrington de Gonzalez A. Patterns of proton therapy use in pediatric cancer management in 2016: An international survey. Radiother Oncol. 2019 Mar;132:155-161. doi: 10.1016/j.radonc.2018.10.022. Epub 2018 Nov 7. PMID: 30414759.
  105. Pearlstein KA, Wang K, Amdur RJ, Shen CJ, Dagan R, Weiss J, Grilley-Olson JE, Zanation A, Hackman TG, Thorp BD, Blumberg JM, Patel S, Sheets N, Weissler MC, Mendenhall WM, Chera BS. Quality of Life for Patients With Favorable-Risk HPV-Associated Oropharyngeal Cancer After De-intensified Chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):646-653. doi: 10.1016/j.ijrobp.2018.10.033. Epub 2018 Nov 2. PMID: 30395903 Clinical Trial.
  106. Mokhtech M, Morris CG, Indelicato DJ, Rutenberg MS, Amdur RJ. Patterns of Failure in Patients With Adult Medulloblastoma Presenting Without Extraneural Metastasis. Am J Clin Oncol. 2018 Oct;41(10):1015-1018. doi: 10.1097/COC.0000000000000407. PMID: 29045264.
  107. Bass JK, Huang J, Hua CH, Bhagat SP, Mendel LL, Onar-Thomas A, Indelicato DJ, Merchant TE. Auditory Outcomes in Patients Who Received Proton Radiotherapy for Craniopharyngioma. Am J Audiol. 2018 Sep 12;27(3):306-315. doi: 10.1044/2018_AJA-18-0026. PMID: 30073327 Clinical Trial.
  108. Bradley JA, Kayton ML, Chi YY, Hawkins DS, Tian J, Breneman J, Wolden SL, Walterhouse D, Rodeberg DA, Donaldson SS. Treatment Approach and Outcomes in Infants With Localized Rhabdomyosarcoma: A Report From the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):19-27. doi: 10.1016/j.ijrobp.2018.08.017. Epub 2018 Aug 20. PMID: 30138647.
  109. Dabaja BS, Hoppe BS, Plastaras JP, Newhauser W, Rosolova K, Flampouri S, Mohan R, Mikhaeel NG, Kirova Y, Specht L, Yahalom J. Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines. Blood. 2018 Oct 18;132(16):1635-1646. doi: 10.1182/blood-2018-03-837633. Epub 2018 Aug 14. PMID: 30108066. 
  110. Lucas JT Jr, Pappo AS, Wu J, Indelicato DJ, Krasin MJ. Excessive Treatment Failures in Patients With Parameningeal Rhabdomyosarcoma With Reduced-dose Cyclophosphamide and Delayed Radiotherapy.  J Pediatr Hematol Oncol. 2018 Jul;40(5):387-390. doi: 10.1097/MPH.0000000000001188. PMID: 29683960.
  111. Peterson RK, Ashford JM, Scott SM, Wang F, Zhang H, Bradley JA, Merchant TE, Conklin HM. Predicting parental distress among children newly diagnosed with craniopharyngioma. Pediatr Blood Cancer. 2018 Oct;65(10):e27287. doi: 10.1002/pbc.27287. Epub 2018 Jun 22. PMID: 29932288.
  112. Weber DC, Habrand JL, Hoppe BS, Hill Kayser C, Laack NN, Langendijk JA, MacDonald SM, McGovern SL, Pater L, Perentesis JP, Thariat J, Timmerman B, Yock TI, Mahajan A. Proton therapy for pediatric malignancies: Fact, figures and costs. A joint consensus statement from the pediatric subcommittee of PTCOG, PROS and EPTN. Radiother Oncol. 2018 Jul;128(1):44-55. doi: 10.1016/j.radonc.2018.05.020. Epub 2018 Jun 21. PMID: 29937209 Review.
  113. Kenney LB, Antal Z, Ginsberg JP, Hoppe BS, Bober SL, Yu RN, Constine LS, van Santen HM, Skinner R, Green DM. Improving Male Reproductive Health After Childhood, Adolescent, and Young Adult Cancer: Progress and Future Directions for Survivorship Research. J Clin Oncol. 2018 Jul 20;36(21):2160-2168. doi: 10.1200/JCO.2017.76.3839. Epub 2018 Jun 6. PMID: 29874140 Review.
  114. Hess CB, Indelicato DJ, Paulino AC, Hartsell WF, Hill-Kayser CE, Perkins SM, Mahajan A, Laack NN, Ermoian RP, Chang AL, Wolden SL, Mangona VS, Kwok Y, Breneman JC, Perentesis JP, Gallotto SL, Weyman EA, Bajaj BVM, Lawell MP, Yeap BY, Yock TI. An Update From the Pediatric Proton Consortium Registry. Front Oncol. 2018 May 24;8:165. doi: 10.3389/fonc.2018.00165. eCollection 2018. PMID: 29881715.
  115. Haas-Kogan D, Indelicato D, Paganetti H, Esiashvili N, Mahajan A, Yock T, Flampouri S, MacDonald S, Fouladi M, Stephen K, Kalapurakal J, Terezakis S, Kooy H, Grosshans D, Makrigiorgos M, Mishra K, Poussaint TY, Cohen K, Fitzgerald T, Gondi V, Liu A, Michalski J, Mirkovic D, Mohan R, Perkins S, Wong K, Vikram B, Buchsbaum J, Kun L. National Cancer Institute Workshop on Proton Therapy for Children: Considerations Regarding Brainstem Injury. Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):152-168. doi: 10.1016/j.ijrobp.2018.01.013. PMID: 29619963 Review.
  116. Liang X, Bradley JA, Zheng D, Rutenberg M, Yeung D, Mendenhall N, Li Z. Prognostic factors of radiation dermatitis following passive-scattering proton therapy for breast cancer. Radiat Oncol. 2018 Apr 19;13(1):72. doi: 10.1186/s13014-018-1004-3. PMID: 29673384.
  117. Okunieff P, Casey-Sawicki K, Lockney NA, Hoppe BS, Enderling H, Pinnix C, Welsh J, Krishnan S, Yothers G, Brown M, Knox S, Bristow R, Spellman P, Mitin T, Nabavizadeh N, Jaboin J, Manning HC, Feng F, Galbraith S, Solanki AA, Harkenrider MM, Tuli R, Decker RH, Finkelstein SE, Hsu CC, Ha CS, Jagsi R, Shumway D, Daly M, Wang TJC, Fitzgerald TJ, Laurie F, Marshall DT, Raben D, Constine L, Thomas CR Jr, Kachnic LA Report from the SWOG Radiation Oncology Committee: Research Objectives Workshop 2017. Clin Cancer Res. 2018 Aug 1;24(15):3500-3509. doi: 10.1158/1078-0432.CCR-17-3202. Epub 2018 Apr 16. PMID: 29661779.
  118. Zhu S, Rotondo R, Mendenhall WM, Dagan R, Lewis D, Huh S, Knox G, Tavaniepour D, Sandhu S, Rutenberg MS. Long-Term Outcomes of Fractionated Stereotactic Proton Therapy for Vestibular Schwannoma: A Case Series. Int J Part Ther. 2018 Spring;4(4):37-46. doi: 10.14338/IJPT-17-00032.1. Epub 2018 Jul 26. PMID: 31773014.
  119. Zhu HJ, Hoppe BS, Flampouri S, Louis D, Pirris J, Nichols RC, Henderson RH, Mercado CE. Rationale and early outcomes for the management of thymoma with proton therapy. Transl Lung Cancer Res. 2018 Apr;7(2):106-113. doi: 10.21037/tlcr.2018.04.06. PMID: 29876309.
  120. Hall MD, Bradley JA, Rotondo RL, Hanel R, Shah C, Morris CG, Aldana PR, Indelicato DJ. Risk of Radiation Vasculopathy and Stroke in Pediatric Patients Treated With Proton Therapy for Brain and Skull Base Tumors. Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):854-859. doi: 10.1016/j.ijrobp.2018.03.027. Epub 2018 Mar 29. PMID: 29730064.
  121. Mokhtech M, Rotondo RL, Bradley JA, Sandler ES, Nanda R, Logie N, Aldana PR, Morris CG, Indelicato DJ. Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors. Pediatr Blood Cancer. 2018 Jun;65(6):e26997. doi: 10.1002/pbc.26997. Epub 2018 Jan 30. PMID: 29380526.
  122. Ho CK, Bryant CM, Mendenhall NP, Henderson RH, Mendenhall WM, Nichols RC, Morris CG, Kanmaniraja D, Hamlin DJ, Li Z, Hoppe BS. Long-term outcomes following proton therapy for prostate cancer in young men with a focus on sexual health. Acta Oncol. 2018 May;57(5):582-588. doi: 10.1080/0284186X.2018.1427886. Epub 2018 Jan 23. PMID: 29359988.
  123. Kharod SM, Herman MP, Morris CG, Lightsey J, Mendenhall WM, Mendenhall NP. Radiotherapy in the Management of Orbital Lymphoma: A Single Institution's Experience Over 4 Decades. Am J Clin Oncol. 2018 Jan;41(1):100-106. doi: 10.1097/COC.0000000000000229. PMID: 26398063.
  124. Indelicato DJ, Bradley JA, Rotondo RL, Nanda RH, Logie N, Sandler ES, Aldana PR, Ranalli NJ, Beier AD, Morris CG, Mendenhall NP. Outcomes following proton therapy for pediatric ependymoma. Acta Oncol. 2018 May;57(5):644-648. doi: 10.1080/0284186X.2017.1413248. Epub 2017 Dec 14. PMID: 29239262 Clinical Trial.
  125. Bradley JA, Mendenhall NP. Novel Radiotherapy Techniques for Breast Cancer. Annu Rev Med. 2018 Jan 29;69:277-288. doi: 10.1146/annurev-med-042716-103422. Epub 2017 Dec 1. PMID: 29195057 Review.
  126. Zhu HJ, Nichols RC Jr, Henderson RH, Morris CG, Pham DC, Jones L, Hoppe BS. Proton therapy in stage II-IV non-small cell lung cancer: pattern of care and impact on trial accrual. Acta Oncol. 2018 May;57(5):692-693. doi: 10.1080/0284186X.2017.1398413. Epub 2017 Nov 6. PMID: 29103341.
  127. Pedersen J, Petersen JBB, Stokkevåg CH, Ytre-Hauge KS, Flampouri S, Li Z, Mendenhall N, Muren LP. Biological dose and complication probabilities for the rectum and bladder based on linear energy transfer distributions in spot scanning proton therapy of prostate cancer. Acta Oncol. 2017 Nov;56(11):1413-1419. doi: 10.1080/0284186X.2017.1373198. Epub 2017 Oct 17. PMID: 2903709.
  128. Tseng YD, Cutter DJ, Plastaras JP, Parikh RR, Cahlon O, Chuong MD, Dedeckova K, Khan MK, Lin SY, McGee LA, Shen EY, Terezakis SA, Badiyan SN, Kirova YM, Hoppe RT, Mendenhall NP, Pankuch M, Flampouri S, Ricardi U, Hoppe BS. Evidence-based Review on the Use of Proton Therapy in Lymphoma From the Particle Therapy Cooperative Group (PTCOG) Lymphoma Subcommittee. Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):825-842. doi: 10.1016/j.ijrobp.2017.05.004. Epub 2017 Sep 21. PMID: 28943076 Review.
  129. Hoppe BS, Hill-Kayser CE, Tseng YD, Flampouri S, Elmongy HM, Cahlon O, Mendenhall NP, Maity A, McGee LA, Plastaras JP. Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma. Ann Oncol. 2017 Sep 1;28(9):2179-2184. doi: 10.1093/annonc/mdx287. PMID: 28911093.
  130. Cramer SL, Li R, Ali S, Bradley JA, Kim HK, Pressey JG. Successful Treatment of Recurrent Primitive Myxoid Mesenchymal Tumor of Infancy With BCOR Internal Tandem Duplication. J Natl Compr Canc Netw. 2017 Jul;15(7):868-871. doi: 10.6004/jnccn.2017.0124. PMID: 28687574.
  131. Indelicato DJ, Bradley JA, Sandler ES, Aldana PR, Sapp A, Gains JE, Crellin A, Rotondo RL. Clinical outcomes following proton therapy for children with central nervous system tumors referred overseas. Pediatr Blood Cancer. 2017 Dec;64(12). doi: 10.1002/pbc.26654. Epub 2017 May 24. PMID: 28544746.
  132. Fournier-Goodnight AS, Ashford JM, Merchant TE, Boop FA, Indelicato DJ, Wang L, Zhang H, Conklin HM. Neurocognitive functioning in pediatric craniopharyngioma: performance before treatment with proton therapy. J Neurooncol. 2017 Aug;134(1):97-105. doi: 10.1007/s11060-017-2492-y. Epub 2017 May 24.PMID: 28540667 Clinical Trial.
  133. Filippi AR, Levis M, Parikh R, Hoppe B. Optimal Therapy for Early-Stage Hodgkin's Lymphoma: Risk Adapting, Response Adapting, and Role of Radiotherapy. Curr Oncol Rep. 2017 May;19(5):34. doi: 10.1007/s11912-017-0592-7. PMID: 28365830 Review.
  134. Hitchcock KE, Nichols RC, Morris CG, Bose D, Hughes SJ, Stauffer JA, Celinski SA, Johnson EA, Zaiden RA, Mendenhall NP, Rutenberg MS. Feasibility of pancreatectomy following high-dose proton therapy for unresectable pancreatic cancer.  World J Gastrointest Surg. 2017 Apr 27;9(4):103-108. doi: 10.4240/wjgs.v9.i4.103. PMID: 28503258.
  135. Fjæra LF, Li Z, Ytre-Hauge KS, Muren LP, Indelicato DJ, Lassen-Ramshad Y, Engeseth GM, Brydøy M, Mairani A, Flampouri S, Dahl O, Stokkevåg CH. Linear energy transfer distributions in the brainstem depending on tumour location in intensity-modulated proton therapy of paediatric cancer. Acta Oncol. 2017 Jun;56(6):763-768. doi: 10.1080/0284186X.2017.1314007. Epub 2017 Apr 19. PMID: 28423966.
  136. Nanda R, Flampouri S, Mendenhall NP, Indelicato DJ, Jones LM, Seeram VK, Hoppe BS. Pulmonary Toxicity Following Proton Therapy for Thoracic Lymphoma. Int J Radiat Oncol Biol Phys. 2017 Oct 1;99(2):494-497. doi: 10.1016/j.ijrobp.2017.04.001. Epub 2017 Apr 11. PMID: 28872001.
  137. Bradley JA, Ho MW, Li Z, Liang X, Rutenberg M, Dagan R, Mendenhall NP. A Technical Guide for Passive Scattering Proton Radiation Therapy for Breast Cancer. Int J Part Ther. 2017 Spring;3(4):473-484. doi: 10.14338/IJPT-16-00025.1. Epub 2017 Jul 11.PMID: 31772997.
  138. Kumar RS, Rotondo RL, Bradley JA, Vern-Gross T, Huh S, Indelicato DJ. Mid-treatment magnetic resonance imaging in pediatric intracranial low-grade gliomas treated with proton beam therapy. Acta Oncol. 2017 Sep;56(9):1243-1247. doi: 10.1080/0284186X.2017.1306105. Epub 2017 Mar 24.PMID: 28339304.
  139. Henderson RH, Bryant C, Hoppe BS, Nichols RC, Mendenhall WM, Flampouri S, Su Z, Li Z, Morris CG, Mendenhall NP. Five-year outcomes from a prospective trial of image-guided accelerated hypofractionated proton therapy for prostate cancer. Acta Oncol. 2017 Jul;56(7):963-970. doi: 10.1080/0284186X.2017.1287946. Epub 2017 Feb 22. PMID: 28514929.
  140. Dhakal S, Advani R, Ballas LK, Dabaja BS, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Younes A, Constine LS; Expert Panel on Radiation Oncology–Lymphoma. ACR Appropriateness Criteria® Hodgkin Lymphoma-Favorable Prognosis Stage I and II. Am J Clin Oncol. 2016 Dec;39(6):535-544. doi: 10.1097/COC.0000000000000331. PMID: 27643717 Review.
  141. Cassidy RJ, Indelicato DJ, Gibbs CP, Scarborough MT, Morris CG, Zlotecki RA. Function Preservation After Conservative Resection and Radiotherapy for Soft-tissue Sarcoma of the Distal Extremity: Utility and Application of the Toronto Extremity Salvage Score (TESS). Am J Clin Oncol. 2016 Dec;39(6):600-603. doi: 10.1097/COC.0000000000000107. PMID: 25036470.
  142. Greenwalt JC, Indelicato DJ, Amdur RJ, Morris CG, Kirwan JM, Mendenhall WM. Long-term Outcomes Following Radiotherapy for Adolescent Patients With Nonmetastatic WHO Type III Nasopharyngeal Carcinoma. Am J Clin Oncol. 2016 Dec;39(6):581-585. doi: 10.1097/COC.0000000000000097. PMID: 24937634.
  143. Lee KA, O'Sullivan C, Daly P, Pears J, Owens C, Timmermann B, Ares C, Combs SE, Indelicato D, Capra M. Proton therapy in paediatric oncology: an Irish perspective. Ir J Med Sci. 2017 Aug;186(3):577-582. doi: 10.1007/s11845-016-1520-9. Epub 2016 Oct 15. PMID: 27744643.
  1. Dagan R, Bryant CM, Bradley JA, Indelicato DJ, Rutenberg M, Rotondo R, Morris CG, Mendenhall WM. A Prospective Evaluation of Acute Toxicity from Proton Therapy for Targets of the Parotid Region. Int J Part Ther. 2016 Fall;3(2):285-290. doi: 10.14338/IJPT-16-00010.2. Epub 2016 Dec 30. PMID: 31772979.
  2. Indelicato DJ, Merchant T, Laperriere N, Lassen Y, Vennarini S, Wolden S, Hartsell W, Pankuch M, Brandal P, Law CK, Taylor R, Laskar S, Okcu MF, Bouffet E, Mandeville H, Björk-Eriksson T, Nilsson K, Nyström H, Constine LS, Story M, Timmermann B, Roberts K, Kortmann RD. Consensus Report From the Stockholm Pediatric Proton Therapy Conference. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):387-392. doi: 10.1016/j.ijrobp.2016.06.2446. PMID: 27598806.
  3. Hoppe BS, Tsai H, Larson G, Laramore GE, Vargas C, Tseng YD, Dunn M, McGee L, Cahlon O, Hartsell W. Proton therapy patterns-of-care and early outcomes for Hodgkin lymphoma: results from the Proton Collaborative Group Registry. Acta Oncol. 2016 Nov;55(11):1378-1380. doi: 10.1080/0284186X.2016.1197422. Epub 2016 Aug 31. PMID: 27579554 Clinical Trial.
  4. Vern-Gross TZ, Indelicato DJ, Bradley JA, Rotondo RL. Patterns of Failure in Pediatric Rhabdomyosarcoma After Proton Therapy. Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):1070-1077. doi: 10.1016/j.ijrobp.2016.08.028. Epub 2016 Aug 30. PMID: 27742542.
  5. Bryant C, Henderson RH, Hoppe BS, Mendenhall WM, Nichols RC, Su Z, Li Z, Mendenhall NP. Controversies in proton therapy for prostate cancer. Chin Clin Oncol. 2016 Aug;5(4):55. doi: 10.21037/cco.2016.08.02. PMID: 27558255 Review.
  6. Roberts KB, Younes A, Hodgson DC, Advani R, Dabaja BS, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Constine LS; Expert Panel on Radiation OncologyLymphoma. ACR Appropriateness Criteria® Hodgkin Lymphoma-Unfavorable Clinical Stage I and II. Am J Clin Oncol. 2016 Aug;39(4):384-95. doi: 10.1097/COC.0000000000000294. PMID: 27299425 Review.
  7. Hoppe BS, Harris S, Rhoton-Vlasak A, Bryant C, Morris CG, Dagan R, Nichols RC, Mendenhall WM, Henderson RH, Li Z, Mendenhall NP. Sperm preservation and neutron contamination following proton therapy for prostate cancer study. Acta Oncol. 2017 Jan;56(1):17-20. doi: 10.1080/0284186X.2016.1205219. Epub 2016 Jul 15. PMID: 27420031.
  8. Bryant CS, Smith TL, Henderson RH, Hoppe BS, Mendenhall WM, Nichols RC, Morris CG, Williams CR, Su Z, Li Z, Lee D, Mendenhall NP. Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life Following Delivery of Dose-Escalated Image-Guided Proton Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2016 May;95(1):435-43. doi: 10.1016/j.ijrobp.2016.02.038. Epub 2016 Feb 16.
  9. Indelicato DJ, Rotondo RL, Begosh-Mayne D, Scarborough MT, Gibbs CP, Morris CG, Mendenhall WM. A Prospective Outcomes Study of Proton Therapy for Chordomas and Chondrosarcomas of the Spine. Int J Radiat Oncol Biol Phys. 2016 May; 95(1):297-303. doi:10.1016/j.ijrobp.2016.01.057. Epub 2016 Feb 5.
  10. Dagan R, Bryant CS, Li Z, Yeung D, Justice J, Dzieglewiski P, Werning J, Fernandes R, Pirgousis P, Lanza DC, Morris CG, Mendenhall WM. Outcomes of Sinonasal Cancer Treated With Proton Therapy. Int J Radiat Oncol Biol Phys. 2016 May; 95(1):377-85. doi:10.1016/j.ijrobp.2016.02.019. Epub 2016 Feb 11.
  11. Jacola LM, Conklin HM, Scoggins MA, Ashford JM, Merchant TE, Mandrell BN, Ogg RJ, Curtis E, Wise MS, Indelicato DJ, Crabtree VM. Investigating the Role of Hypothalamic Tumor Involvement in Sleep and Cognitive Outcomes Among Children Treated for Craniopharyngioma. J Pediatr Psychol. 2016 Jul; 41(6):610-22. doi: 10.1093/jpepsy/jsw026. Epub 2016 May 16. PMID: 27189690
  12. Wray J, Flampouri S, Slayton W, Joyce M, Sandler E, Morris CG, Li Z, Indelicato DJ, Mendenhall NP, Hoppe BS. Proton Therapy for Pediatric Hodgkin Lymphoma. Pediatr Blood Cancer. 2016 Sep; 63(9):1522-6. doi: 10.1002/pbc.26044. Epub 2016 May 3. PMID: 27149120.
  13. Mendenhall WM, Dagan R, Bryant CM, Amdur RJ. Definitive Radiotherapy for Skin and Adenoid Cystic Carcinoma with Perineural Invasion. J Neurol Surg B Skull Base. 2016 Apr; 77(2):169-72. doi: 10.1055/s-0036-1579545. Epub 2016 Mar 18. PMID: 27123393.
  14. Matysiak W, Yeung D, Slopsema R, Li Z. Evaluation of the range shifter model for proton pencil-beam scanning for the Eclipse v.11 treatment planning system. J Appl Clin Med Phys. 2016 Mar 8; 17(2):391-404. doi: 10.1120/jacmp.v17i2.5798. PMID: 27074461.
  15. Chang JY, Jabbour SK, De Ruysscher D, Schild SE, Simone CB 2nd, Rengan R, Feigenberg S, Khan AJ, Choi NC, Bradley JD, Zhu XR, Lomax AJ, Hoppe B; International Particle Therapy Co-operative Group (PTCOG) Thoracic Subcommittee. Consensus Statement on Proton Therapy in Early-Stage and Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2016 May 1; 95(1):505-516. doi: 10.1016/j.ijrobp.2016.01.036. Epub 2016 Jan 23. PMID: 27084663.
  16. Holtzman AL, Hoppe BS, Letter HP, Bryant CS, Nichols RC, Henderson RH, Mendenhall WM, Morris CG, Williams CR, Li Z, Mendenhall NP. Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused Ultrasound. Int J Radiat Oncol Biol Phys. 2016 May;95(1):465-71. doi: 10.1016/j.ijrobp.2015.12.351. Epub 2015 Dec 18.
  17. Hoppe BS, Henderson RH, Pham D, Cury JD, Bajwa A, Morris CG, D’Agostino H, Flampouri S, Huh S, Li Z, McCook B, Nichols RC. A Phase 2 Trial of Concurrent Chemotherapy and Proton Therapy for Stage III Non-Small Cell Lung Cancer: Results and Reflections Following Early Closure of a Single-Institution Study. Int J Radiat Oncol Biol Phys. 2016 May;95(1):517-22. doi:10.1016/j.ijrobp.2015.11.004. Epub 2015 Nov 8.
  18. Bradley JA, Dagan R, Ho MW, Rutenberg M, Morris CG, Li Z, Mendenhall NP. Initial Report of a Prospective Dosimetric and Clinical Feasibility Trial Demonstrates the Potential of Protons to Increase the Therapeutic Ratio in Breast Cancer Compared With Photons. Int J Radiat Oncol Biol Phys. 2016 May; Vol. 95(1):411-21. doi: 10.1016/j.ijrobp.2015.09.018. Epub 2015 Sep 25. pii: S0360-3016(15)03348-9. PubMed PMID: 26611875.
  19. Lee DT, Mendenhall NP, Smith TL, Morris CG, Nichols RC, Bryant CS, Henderson RH, Mendenhall WM, Costa J, Williams CR, Li Z, Hoppe BS. Patient-Reported Quality of Life in Men with Transurethral Resection of the Prostate Undergoing Proton Therapy for Management of Prostate Cancer. Int J Particle Ther. 2016 Apr;2(4):518-24.
  20. Dabaja BS, Advani R, Hodgson DC, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Younes A, Constine LS. ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma. Am J Clin Oncol. 2015 Dec;38(6):610-20. doi: 10.1097/COC.0000000000000215. PubMed PMID: 26583344.
  21. Rotondo RL, Folkert W, Liebsch NJ, Chen YL, Pedlow FX, Schwab JH, Rosenberg AE, Nielsen GP, Szymonifka J, Ferreira AE, Hornicek FJ, Delaney TF. High-dose proton-based radiation therapy in the management of spine chordomas: outcomes and clinicopathological prognostic factors. J Neurosurg Spine. 2015 Dec;23(6):788-97. doi: 10.3171/2015.3.SPINE14716. Epub 2015 Sep 4. PubMed PMID: 26340383.
  22. Vern-Gross TZ, Bradley JA, Rotondo RL, Indelicato DJ. Fertility in childhood cancer survivors following cranial irradiation for primary central nervous system and skull base tumors. Radiother Oncol. 2015 Nov;117(2):195-205. doi: 10.1016/j.radonc.2015.10.001. Epub 2015 Oct 20. Review. PubMed PMID: 26475251.
  23. Nichols RC, Huh S, Li Z, Rutenberg M. Proton therapy for pancreatic cancer. World J Gastrointest Oncol. 2015 Sep 15;7(9):141-7. doi: 10.4251/wjgo.v7.i9.141. Review. PubMed PMID: 26380057; PubMed Central PMCID: PMC4569591.
  24. Uh J, Merchant TE, Li Y, Li X, Sabin ND, Indelicato DJ, Ogg RJ, Boop FA, Jane JA Jr, Hua C. Effects of Surgery and Proton Therapy on Cerebral White Matter of Craniopharyngioma Patients. Int J Radiat Oncol Biol Phys. 2015 Sep 1;93(1):64-71. doi: 10.1016/j.ijrobp.2015.05.017. Epub 2015 May 16. PubMed PMID: 26279025.
  25. Sachsman S, Flampouri S, Li Z, Lynch J, Mendenhall NP, Hoppe BS. Proton therapy in the management of non-Hodgkin lymphoma. Leuk Lymphoma. 2015 Sep;56(9):2608-12. doi: 10.3109/10428194.2015.1014364. Epub 2015 May 18. PubMed PMID: 25669925.
  26. Hua C, Shulkin BL, Indelicato DJ, Li Y, Li X, Boop FA, Merchant TE. Postoperative cerebral glucose metabolism in pediatric patients receiving proton therapy for craniopharyngioma. J Neurosurg Pediatr. 2015 Aug 21:1-7. PubMed PMID: 26295365.
  27. Baldini EH, Abrams RA, Bosch W, Roberge D, Haas RL, Catton CN, Indelicato DJ, Olsen JR, Deville C, Chen YL, Finkelstein SE, DeLaney TF, Wang D. Retroperitoneal Sarcoma Target Volume and Organ at Risk Contour Delineation Agreement Among NRG Sarcoma Radiation Oncologists. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1053-9. doi: 10.1016/j.ijrobp.2015.04.039. Epub 2015 May 1. PubMed PMID:  26194680; PubMed Central PMCID: PMC4684186.
  28. Sachsman S, Hoppe BS, Mendenhall NP, Holtzman A, Li Z, Slayton W, Joyce M, Sandler E, Flampouri S. Proton therapy to the subdiaphragmatic region in the management of patients with Hodgkin lymphoma. Leuk Lymphoma. 2015 Jul;56(7):2019-24. doi: 10.3109/10428194.2014.975802. Epub 2014 Nov 19. PubMed PMID: 25315071.
  29. Baldini EH, Wang D, Haas RL, Catton CN, Indelicato DJ, Kirsch DG, Roberge D, Salerno K, Deville C, Guadagnolo BA, O'Sullivan B, Petersen IA, Le Pechoux C, Abrams RA, DeLaney TF. Treatment Guidelines for Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Preliminary Consensus of an International Expert Panel. Int J Radiat Oncol Biol Phys. 2015 Jul 1;92(3):602-612. doi: 10.1016/j.ijrobp.2015.02.013. Review. PubMed PMID: 26068493.
  30. Kole TP, Nichols RC, Lei S, Wu B, Huh SN, Morris CG, Lee S, Tong M, Mendenhall NP, Dritschilo A, Collins SP. A dosimetric comparison of ultra-hypofractionated passively scattered proton radiotherapy and stereotactic body radiotherapy (SBRT) in the definitive treatment of localized prostate cancer. Acta Oncol. 2015 Jun;54(6):825-31. doi: 10.3109/0284186X.2014.953260. Epub 2014 Sep 17. PubMed PMID: 25227898.
  31. Zeitlin R, McPhillips M, Harris S, Mandia S, Williams CR, Costa J, Morris CG, Su Z, Li Z, Mendenhall NP. Fiducial Markers, Saline, and Balloons to Locate and Stabilize the Prostate during Proton Therapy. Int J Particle Ther. 2015 Jun;2(1)29-36.
  32. Slopsema R, Mamalui M, Rutenberg M, Yeung D, Li Z, Bolling J, Flampouri S, Dagan R. TH-CD-BRA-01: The Benefit of Adjunct CT Imaging in Clip-Based Treatment of Ocular Melanoma with Protons. Med Phys. 2015 Jun;42(6):3725. doi: 10.1118/1.4926217. PubMed PMID: 26129517.
  33. Su Z, Dagan R, Li Z. SU-E-T-686: SBRT 4-Dimensional Treatment Planning for Vero Dynamic Tumor Tracking Lung Patients. Med Phys. 2015 Jun;42(6):3494. doi: 10.1118/1.4925049. PubMed PMID: 26128351.
  34. Flampouri S, Li Z, Hoppe B. SU-E-T-622: Planning Technique for Passively-Scattered Involved-Node Proton Therapy of Mediastinal Lymphoma with Consideration of Cardiac Motion. Med Phys. 2015 Jun;42(6):3479. doi: 10.1118/1.4924985. PubMed PMID: 26128284.
  35. Kryck E, Mamalui-Hunter M, Li Z, Slopsema R. SU-E-T-03: 3 Year Clinical Experience with the IBA Proton Eyeline. Med Phys. 2015 Jun;42(6):3331. doi: 10.1118/1.4924364. PubMed PMID: 26127670.
  36. Pirlepesov F, Shin J, Moskvin VP, Gray J, Li Z, Hua C, Gajjar A, Krasin MJ, Merchant TE, Farr JB. SU-F-BRD-14: Dose Weighted Linear Energy Transfer Analysis  of Critical Structures in Proton Therapy of Pediatric Brain Tumor Patients. Med Phys. 2015 Jun;42(6):3528. doi: 10.1118/1.4925193. PubMed PMID: 26128490.
  37. Petroccia H, Li Z, Mendenhall N, Bolch W. SU-E-T-559: Monte Carlo Simulation of Cobalt-60 Teletherapy Unit Modeling In-Field and Out-Of-Field Doses for Applications in Computational Radiation Dosimetry. Med Phys. 2015 Jun;42(6):3464. doi: 10.1118/1.4924921. PubMed PMID: 26128224.
  38. Mendenhall WM, Henderson RH, Costa JA, Hoppe BS, Dagan R, Bryant CM, Nichols RC, Williams CR, Harris SE, Mendenhall NP. Hemorrhagic Radiation Cystitis. Am J Clin Oncol. 2015 Jun;38(3):331-6. PubMed PMID: 24322335.
  39. Hoppe BS, Hoppe RT. Expert radiation oncologist interpretations of involved-site radiation therapy guidelines in the management of Hodgkin lymphoma. Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):40-5. doi: 10.1016/j.ijrobp.2015.02.008. PubMed PMID: 25863752.
  40. Hoppe BS, Bryant C, Sandler HM. Radiation for prostate cancer: intensity modulated radiation therapy versus proton beam. J Urol. 2015 Apr;193(4):1089-91. doi: 10.1016/j.juro.2015.01.069. Epub 2015 Jan 15. PubMed PMID: 25598137.
  41. Yeung D, Boes P, Ho MW, Li Z. A Web application for the management of clinical workflow in image-guided and adaptive proton therapy for prostate cancer treatments. J Appl Clin Med Phys. 2015 May 8;16(3):5503. doi: 10.1120/jacmp.v16i3.5503. PubMed PMID: 26103504.
  42. Hoppe B. Reply by Author. J Urol. 2015 Nov;194(5):1508. PMID: 26764431. 
  43. Hua C, Shulkin BL, Indelicato DJ, Li Y, Li X, Boop FA, Merchant TE. Postoperative cerebral glucose metabolism in pediatric patients receiving proton therapy for craniopharyngioma. J Neurosurg Pediatr. 2015 Nov;16(5):567-573. doi: 10.3171/2015.4.PEDS159. Epub 2015 Aug 21. PMID: 26295365.
  44. Christopherson K, Malyapa RS, Werning JW, Morris CG, Kirwan J, Mendenhall WM. Radiation therapy for mucosal melanoma of the head and neck. Am J Clin Oncol. 2015 Feb; 38(1):87-9. doi: 10.1097/COC.0b013e31828d73bf. PMID: 23563215.
  45. Martin NE, Massey L, Stowell C, Bangma C, Briganti A, Bill-Axelson A, Blute M, Catto J, Chen RC, D'Amico AV, Feick G, Fitzpatrick JM, Frank SJ, Froehner M, Frydenberg M, Glaser A, Graefen M, Hamstra D, Kibel A, Mendenhall N, Moretti K, Ramon J, Roos I, Sandler H, Sullivan FJ, Swanson D, Tewari A, Vickers A, Wiegel T, Huland H. Defining a standard set of patient-centered outcomes for men with localized prostate cancer. Eur Urol. 2015 Mar; 67(3):460-7. doi: 10.1016/j.eururo.2014.08.075. Epub 2014 Sep 16. PMID: 25234359.
  46. Scott MT, Indelicato DJ, Morris CG, Gibbs CP Jr, Scarborough MT, Reith JD, Marcus RB Jr, Zlotecki R, Mendenhall WM. Radiation therapy for hemangioendothelioma: the university of Florida experience. Am J Clin Oncol. 2014 Aug;37(4):360-3. doi: 10.1097/COC.0b013e31827a7cde. PMID: 23275275.
  47. Slopsema RL, Mamalui M, Zhao T, Yeung D, Malyapa R, Li Z. Dosimetric properties of a proton beamline dedicated to the treatment of ocular disease. Med Phys. 2014 Jan; 41(1):011707. doi: 10.1118/1.4842455. PMID: 24387499.
  48. Christopherson K, Werning JW, Malyapa RS, Morris CG, Mendenhall WM. Radiotherapy for sinonasal undifferentiated carcinoma. Am J Otolaryngol. 2014 Mar-Apr;35(2):141-6. doi: 10.1016/j.amjoto.2013.10.001. Epub 2013 Oct 21. PMID: 24268566.
  49. Colaco RJ, Hoppe BS, Flampouri S, McKibben BT, Henderson RH, Bryant C, Nichols RC, Mendenhall WM, Li Z, Su Z, Morris CG, Mendenhall NP. Rectal Toxicity After Proton Therapy For Prostate Cancer: An Analysis of Outcomes of Prospective Studies Conducted at the University of Florida Proton Therapy Institute. Int J Radiat Oncol Biol Phys. 2015 Jan 1;91(1):172-81. doi: 10.1016/j.ijrobp.2014.08.353. Epub 2014 Nov 5. PubMed PMID: 25442338.
  50. Sachsman S, Nichols RC, Morris CG, Zaiden R, Johnson EA, Awad Z, Bose D, Ho MW, Huh SN, Li Z, Kelly P, Hoppe BS. Proton Therapy and Concomitant Capecitabine for Non-Metastatic Unresectable Pancreatic Adenocarcinoma. Int J Particle Ther. 2014;1(3):692–701.
  51. Mendenhall WM, Costa JA, Williams CR, Harris SE, Mandia SE, Hoppe BS, Henderson RH, Bryant CM, Nichols RC, Mendenhall NP. Bacterial Urinary Tract Infection after Fiducial Marker Placement or Prostate Biopsy. Int J Particle Ther. 2014;1(3):745–758.
  52. Cooper SL, Rotondo R, Bradley J, Cox R, Indelicato DJ. Proton therapy for radiation-induced parameningeal rhabdomyosarcoma. Appl Radiat Oncol. 2014 Dec;3(4):14-8.
  53. Xu N, Ho MW, Li Z, Morris CG, Mendenhall NP. Can proton therapy improve the therapeutic ratio in breast cancer patients at risk for nodal disease? Am J Clin Oncol. 2014 Dec;37(6):568-74. doi: 10.1097/COC.0b013e318280d614. PubMed PMID: 23466577.
  54. Ho CK, Flampouri S, Hoppe BS. Proton therapy in the management of lymphoma. Cancer J. 2014 Nov-Dec;20(6):387-92. doi: 10.1097/PPO.0000000000000076. PubMed PMID: 25415683.
  55. Ha CS, Hodgson DC, Advani R, Dabaja BS, Dhakal S, Flowers CR, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith S, Terezakis SA, Winkfield KM, Younes A, Constine LS. ACR appropriateness criteria follow-up of Hodgkin lymphoma. J Am Coll Radiol. 2014 Nov;11(11):1026-1033.e3. doi: 10.1016/j.jacr.2014.07.038. Epub 2014 Sep 30. PubMed PMID: 25278496.
  56. Indelicato DJ, Flampouri S, Rotondo RL, Bradley JA, Morris CG, Aldana PR, Sandler E, Mendenhall NP. Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy. Acta Oncol. 2014 Oct;53(10):1298-304. doi: 10.3109/0284186X.2014.957414. Epub 2014 Oct 3. PubMed PMID: 25279957.
  57. Chen H, Matysiak W, Flampouri S, Slopsema R, Li Z. Dosimetric evaluation of hybrid brass/stainless-steel apertures for proton therapy. Phys Med Biol. 2014 Sep 7;59(17):5043-60. doi: 10.1088/0031-9155/59/17/5043. Epub 2014 Aug 13. PubMed PMID: 25119333.
  58. Christopherson KM, Bradley JA, Rotondo RL, Pincus DW, Fort JA, Morris CG, Mendenhall NP, Marcus RB Jr, Indelicato DJ. Local control in non-metastatic medulloblastoma. Acta Oncol. 2014 Sep;53(9):1151-7. doi: 10.3109/0284186X.2014.932434. Epub 2014 Jul 3. PubMed PMID: 24991891.
  59. Holtzman A, Hoppe BS, Li Z, Su Z, Slayton WB, Ozdemir S, Joyce M, Sandler E, Mendenhall NP, Flampouri S. Advancing the Therapeutic Index in Stage III/IV Pediatric Hodgkin Lymphoma with Proton Therapy. Int J Particle Ther. 2014;1(2):343–356.
  60. Chang AL, Yock TI, Mahajan A, Hill-Kaiser C, Keole S, Loredo L, Cahlon O, McMullen KP, Hartsell W, Indelicato DJ. Pediatric Proton Therapy: Patterns of Care across the United States. Int J Particle Ther. 2014;1(2):357-67.
  61. Bradley JA, Indelicato DJ. Craniopharyngioma and Proton Therapy. Int J Particle Ther. 2014;1(2):386–398.
  62. Mendenhall WM, McKibben BT, Hoppe BS, Nichols RC, Henderson RH, Mendenhall NP. Management of Radiation Proctitis. Am J Clin Oncol. 2014 Oct;37(5):517-23. PubMed PMID: 23241500.
  63. Rutenberg MS, Flampouri S, Hoppe BS. Proton therapy for Hodgkin lymphoma. Curr Hematol Malig Rep. 2014 Sep;9(3):203-11. doi: 10.1007/s11899-014-0212-7. PubMed PMID: 24842407.
  64. Slopsema RL, Lin L, Flampouri S, Yeung D, Li Z, McDonough JE, Palta J. Development of a golden beam data set for the commissioning of a proton double-scattering system in a pencil-beam dose calculation algorithm. Med Phys. 2014 Sep;41(9):091710. doi: 10.1118/1.4893281. PubMed PMID: 25186385.
  65. Mendenhall WM, Henderson RH, Hoppe BS, Nichols RC, Mendenhall NP. Salvage of Locally Recurrent Prostate Cancer After Definitive Radiotherapy. Am J Clin Oncol. 2014 Aug;37(4):411-6.  PubMed PMID: 22772432.
  66. Flampouri S, Hoppe BS, Slopsema RL, Li Z. Beam-specific planning volumes for scattered-proton lung radiotherapy. Phys Med Biol. 2014 Aug 21;59(16):4549-66. doi: 10.1088/0031-9155/59/16/4549. Epub 2014 Jul 28. PubMed PMID: 25069103.
  67. Hoppe BS, Flampouri S, Zaiden R, Slayton W, Sandler E, Ozdemir S, Dang NH, Lynch JW, Li Z, Morris CG, Mendenhall NP. Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study. Int J Radiat Oncol Biol Phys. 2014 Aug 1;89(5):1053-9. doi: 10.1016/j.ijrobp.2014.04.029. Epub 2014 Jun 10. PubMed PMID: 24928256.
  68. Kil WJ, Mendenhall NP, Morris CG, Nichols RC, Henderson RH, Mendenhall WM, Bryant C, Williams C, Li Z, Hoppe BS. Patient-reported Hip Symptoms following Treatment with Proton Therapy for Prostate Cancer. Int J Particle Ther. 2014 Apr;1(1):14-21.
  69. Beltran C, Jia Y, Slopsema R, Yeung D, Li Z. A simplified methodology to produce Monte Carlo dose distributions in proton therapy. J Appl Clin Med Phys. 2014 Jul 8;15(4):4413. doi: 10.1120/jacmp.v15i4.4413. PubMed PMID: 25207391.
  70. Bryant C, Mendenhall NP, Henderson RH, Nichols RC, Mendenhall WM, Morris CG, Williams C, Su Z, Li Z, Hoppe BS. Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer? Am J Clin Oncol. 2014 Jul 2. [Epub ahead of print] PubMed PMID: 24710124.
  71. Terezakis SA, Metzger ML, Hodgson DC, Schwartz CL, Advani R, Flowers CR, Hoppe BS, Ng A, Roberts KB, Shapiro R, Wilder RB, Yunes MJ, Constine LS. ACR Appropriateness Criteria Pediatric Hodgkin Lymphoma. Pediatr Blood Cancer. 2014 Jul;61(7):1305-12. doi: 10.1002/pbc.24983. Epub 2014 Feb 24. Review. PubMed PMID: 24616347.
  72. Christopherson KM, Rotondo RL, Bradley JA, Pincus DW, Wynn TT, Fort JA, Morris CG, Mendenhall NP, Marcus RB Jr, Indelicato DJ. Late toxicity following craniospinal radiation for early-stage medulloblastoma. Acta Oncol. 2014 Apr;53(4):471-80. doi: 10.3109/0284186X.2013.862596. Epub 2014 Feb 24. PubMed PMID: 24564687.
  73. Hoppe BS, Michalski JM, Mendenhall NP, Morris CG, Henderson RH, Nichols RC, Mendenhall WM, Williams CR, Regan MM, Chipman JJ, Crociani CM, Sandler HM, Sanda MG, Hamstra DA. Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer. Cancer. 2014 Apr 1;120(7):1076-82. doi: 10.1002/cncr.28536. Epub 2013 Dec 30. PubMed PMID: 24382757; PubMed Central PMCID: PMC4103169.
  74. Sreeraman R, Indelicato DJ. Proton therapy for the treatment of children with CNS malignancies. CNS Oncol. 2014 Mar;3(2):149-58. doi: 10.2217/cns.14.16. PubMed PMID: 25055020.
  75. Mendenhall NP, Hoppe BS, Nichols RC, Mendenhall WM, Morris CG, Li Z, Su Z, Williams CR, Costa J, Henderson RH. Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):596-602. doi: 10.1016/j.ijrobp.2013.11.007. PubMed PMID: 24521677.
  76. Terezakis SA, Metzger ML, Hodgson DC, Schwartz CL, Advani R, Flowers CR, Hoppe BS, Ng A, Roberts KB, Shapiro R, Wilder RB, Yunes MJ, Constine LS. ACR appropriateness Criteria® pediatric Hodgkin lymphoma. Pediatr Blood Cancer. 2014  Jul;61(7):1305-12. doi: 10.1002/pbc.24983. Epub 2014 Feb 24. PubMed PMID: 24616347.
  77. Colaco RJ, Nichols RC, Huh S, Getman N, Ho MW, Li Z, Morris CG, Mendenhall WM, Mendenhall NP, Hoppe BS. Protons offer reduced bone marrow, small bowel, and urinary bladder exposure for patients receiving neoadjuvant radiotherapy for resectable rectal cancer. J Gastrointest Oncol. 2014 Feb;5(1):3-8. doi: 10.3978/j.issn.2078-6891.2013.041. PubMed PMID: 24490037; PubMed Central PMCID: PMC3904024.
  78. Yeung D, McKenzie C, Indelicato DJ. A dosimetric comparison of intensity-modulated proton therapy optimization techniques for pediatric craniopharyngiomas: a clinical case study. Pediatr Blood Cancer. 2014 Jan;61(1):89-94. doi: 10.1002/pbc.24593. Epub 2013 Sep 2. PubMed PMID: 24000229.
  79. Nichols RC Jr, Hoppe BS. RE: Takatori K, Terashima K, Yoshida R, Horai A, Satake S, Ose T, Kitajima N, Kinoshita Y, Demizu Y, Fuwa N. Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer. J Gastroenterol. 2013; (E-pub only). J Gastrointest Oncol. 2013 Dec;4(4):E33-4. doi: 10.3978/j.issn.2078-6891.2013.048. PubMed PMID: 24294518; PubMed Central PMCID: PMC3819775.
  80. Deraniyagala RL, Yeung D, Mendenhall WM, Li Z, Morris CG, Mendenhall NP, Okunieff P, Malyapa RS. Proton therapy for skull base chordomas: an outcome study from the university of Florida proton therapy institute. J Neurol Surg B Skull Base. 2014 Feb;75(1):53-7. doi: 10.1055/s-0033-1354579. Epub 2013 Sep 9. PubMed PMID: 24498590; PubMed Central PMCID: PMC3912148.
  81. Lee RY, Nichols RC Jr, Huh SN, Ho MW, Li Z, Zaiden R, Awad ZT, Ahmed B, Hoppe BS. Proton therapy may allow for comprehensive elective nodal coverage for patients receiving neoadjuvant radiotherapy for localized pancreatic head cancers. J Gastrointest Oncol. 2013 Dec;4(4):374-9. doi: 10.3978/j.issn.2078-6891.2013.043. PubMed PMID: 24294509; PubMed Central PMCID: PMC3819780.
  82. Mendenhall WM, Hoppe BS, Nichols RC, Henderson RH, Mendenhall NP. When Is Elective Pelvic Lymph Node Irradiation Indicated in Definitive Radiotherapy for Localized Prostate Cancer? Am J Clin Oncol. 2013 Dec;36(6):644-7. PubMed PMID: 22237149.
  83. Mendenhall WM, Henderson RH, Hoppe BS, Nichols RC, Mendenhall NP. Androgen Deprivation Therapy and Definitive Radiotherapy for Prostate Cancer. Am J Clin Oncol. 2013 Oct;36(5):530-4. PubMed PMID: 21694574.
  84. Hoppe BS, Hodgson DC, Advani R, Dabaja BS, Flowers CR, Ha CS, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Terezakis SA, Winkfield KM, Younes A, Constine LS. ACR Appropriateness Criteria: Localized nodal indolent lymphoma. Oncology (Williston Park). 2013 Aug;27(8):786-94. PubMed PMID: 24133827.
  85. Figura N, Hoppe BS, Flampouri S, Su Z, Osian O, Monroe A, Nichols RC. Postoperative proton therapy in the management of stage III thymoma. J Thorac Oncol. 2013 May;8(5):e38-40.
  86. Shi W, Nichols Jr RC, Flampouri S, Li Z, His W, Huh S, Ho MW, Henderson RH, Mendenhall NP, Hoppe BS. Proton-Based Chemoradiation for Synchronous Bilateral Non-Small-Cell Lung Cancers: A Case Report. Thoracic Cancer. 2013 May;4(2):198-202.
  87. Brower JV, Indelicato DJ, Aldana PR, Sandler E, Rotondo R, Mendenhall NP, Marcus RB, Su Z. A Treatment Planning Comparison of Highly Conformal Radiation Therapy for Pediatric Low-Grade Brainstem Gliomas. Acta Oncol. 2013 Apr;52(3): 594-599.
  88. Kil WJ, Nichols RC Jr, Hoppe BS, Morris CG, Marcus RB Jr, Mendenhall WM, Mendenhall NP, Li Z, Costa JA, Williams CR, Henderson RH. Hypofractionated Passively Scattered Proton Radiotherapy for Low- and Intermediate-Risk Prostate Cancer Is Not Associated with Post-Treatment Testosterone Suppression. Acta Oncol. 2013 Apr;52(3): 492–497.
  89. Nichols RC Jr, George TJ, Zaiden RA Jr, Awad ZT, Asbun HJ, Huh S, Ho MW, Mendenhall NP, Morris CG, Hoppe BS. Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity. Acta Oncol. 2013 Apr;52(3):498-505.
  90. Colaco RJ, Huh S, Nichols RC, Morris CG, D'Agostino H, Flampouri S, Li Z, Pham DC, Bajwa AA, Hoppe BS. Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer. Acta Oncol. 2013 Apr;52(3):506-13.
  91. Holtzman A, Li Z, Flampouri S, Slayton W, Sandler E, Mendenhall NP, Hoppe B. Advancing the Therapeutic Index of Pediatric Patients with Stage III Hodgkin Lymphoma with Proton Therapy. Acta Oncol. 2013 Apr;52(3): 592-594.
  92. Holtzman A, Flampouri S, Li Z, Mendenhall NP, Hoppe BS. Proton therapy in a pediatric patient with stage III Hodgkin lymphoma. Acta Oncol. 2013 Apr;52(3):592-4. doi: 10.3109/0284186X.2013.765966. PubMed PMID: 23477362.
  93. Henderson RH, Hoppe BS, Marcus RB Jr, Mendenhall WM, Nichols RC Jr, Li Z, Su Z, Morris CG, Williams CR, Costa J, Mendenhall NP. Urinary Functional Outcomes and Toxicity Five Years after Proton Therapy for Low- and Intermediate-risk Prostate Cancer: Results of Two Prospective Trials. Acta Oncol. 2013 Apr;52(3): 463–469.
  94. Valery R, Mendenhall NP, Nichols RD Jr, Henderson R, Morris CG, Su Z, Mendenhall WM, Williams CR, Li Z, Hoppe BS. Hip Fractures and Pain following Proton Therapy for Management of Prostate Cancer. Acta Oncol. 2013 Apr;52(3): 486-491.
  95. Sabin ND, Merchant TE, Harreld JH, Patay Z, Klimo P Jr, Qaddoumi I, Armstrong GT, Wright K, Gray J, Indelicato DJ, Gajjar A. Imaging Changes in Very Young Children with Brain Tumors Treated with Proton Therapy and Chemotherapy. AJNR Am J Neuroradiol. 2013 Feb;34(2):446-50. PubMed PMID: 22821924.
  96. Hoppe BS, Mamalui-Hunter M, Mendenhall NP, Li Z, Indelicato DJ. Improving the Therapeutic Ratio by Using Proton Therapy in Patients With Stage I or II Seminoma. Am J Clin Oncol. 2013 Feb;36(1):31-7. PubMed PMID: 22134517.
  97. Shi W, Indelicato DJ, Reith J, Smith KB, Morris CG, Scarborough MT, Gibbs CP Jr, Mendenhall WM, Zlotecki RA. Radiotherapy in the management of giant cell tumor of bone. Am J Clin Oncol. 2013 Oct;36(5):505-8. doi: 10.1097/COC.0b013e3182568fb6.PMID: 22781387
  98. Laser BS, Merchant TE, Indelicato DJ, Hua CH, Shulkin BL, Snyder SE. Evaluation of children with craniopharyngioma using carbon-11 methionine PET prior to proton therapy. Neuro Oncol. 2013 Apr;15(4):506-10. doi: 10.1093/neuonc/nos321. Epub 2013 Feb 13. PMID: 23408862.
  99. Indelicato DJ, Finkelstein SE. Dendritic cell immunotherapy in soft tissue sarcoma. Immunotherapy. 2012 Oct;4(10):1023-9. doi: 10.2217/imt.12.106.PMID: 23148754.
  100. Su Z, Slopsema R, Flampouri S, Li Z. SU-E-J-214: Target Intrafraction Motion Dosimetric Impact on 5-Fraction Proton Prostate SBRT. Med Phys. 2012 Jun;39(6Part9):3702. doi: 10.1118/1.4735054. PMID: 28519044.
  101. Slopsema R, Mamalui-Hunter M, Yeung D, Li Z. SU-E-T-297: Proton-Therapy System for Treatment of Macular Degeneration and Ocular Malignancies. Med Phys. 2012. Jun;39(6Part14):3771-3772. doi: 10.1118/1.4735378. PMID: 28517276.
  102. Mendenhall WM, Ferlito A, Takes RP, Bradford CR, Corry J, Fagan JJ, Rinaldo A, Strojan P, Rodrigo JP. Cutaneous head and neck basal and squamous cell carcinomas with perineural invasion. Oral Oncol. 2012 Oct;48(10):918-922. doi: 10.1016/j.oraloncology.2012.02.015. Epub 2012 Mar 15. PMID: 22425152.
  103. Trifiletti D, Amdur RJ, Dagan R, Indelicato DJ, Mendenhall WM, Kirwan JM, Yeung AR, Werning JW, Morris CG. Radiotherapy following gross total resection of adult soft tissue sarcoma of the head and neck. Pract Radiat Oncol. 2012 Oct-Dec;2(4):e121-e128. doi: 10.1016/j.prro.2012.01.003. Epub 2012 Feb 17. PMID: 24674174.
  104. Kil WJ, Nichols RC Jr, Kilkenny JW, Huh SY, Ho MW, Gupta P, Marcus RB, Indelicato DJ. Proton Therapy versus Photon Radiation Therapy for the Management of a Recurrent Desmoid Tumor of the Right Flank: a case report. Radiat Oncol. 2012 Oct 26;7(1):178. PubMed PMID: 23098082.
  105. Jia Y, Beltran C, Indelicato DJ, Flampouri S, Li Z, Merchant TE. Proton therapy dose distribution comparison between Monte Carlo and a treatment planning system for pediatric patients with ependymoma. Med Phys. 2012 Aug;39(8):4742-7. doi: 10.1118/1.4736413. PubMed PMID: 22894399.
  106. Swanson EL, Indelicato DJ, Louis D, Flampouri S, Li Z, Morris CG, Paryani N, Slopsema R. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas. Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1549-57. doi: 10.1016/j.ijrobp.2011.10.014. Epub 2012 Jan 21. PubMed PMID: 22270176.
  107. McGee L, Mendenhall NP, Henderson RH, Morris CG, Nichols RC Jr, Marcus RJ Jr, Li Z, Mendenhall WM, Williams CR, Hoppe BS. Outcomes in men with large prostates (≥ 60 cm(3)) treated with definitive proton therapy for prostate cancer. Acta Oncol. 2013 Apr;52(3): 470-476.
  108. Su Z, Zhao T, Li Z, Hoppe B, Henderson R, Mendenhall W, Nichols RC, Marcus R, Mendenhall N. Reduction of prostate intrafraction motion using gas-release rectal balloons. Med Phys. 2012 Oct;39(10):5869-73. doi: 10.1118/1.4749932. PubMed PMID: 23039625.
  109. Lopatiuk-Tirpak O, Su Z, Li Z, Zeidan OA, Meeks SL, Maryanski MJ. Direct response to proton beam linear energy transfer (LET) in a novel polymer gel dosimeter formulation. Technol Cancer Res Treat. 2012 Oct;11(5):441-5. Epub 2012 May 7. PubMed PMID: 22568627.
  110. Hoppe BS, Flampouri S, Henderson RH, Pham D, Bajwa AA, D'Agostino H, Huh SN, Li Z, Mendenhall NP, Nichols RC. Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: technique and early results. Clin Lung Cancer. 2012 Sep;13(5):352-8. doi: 10.1016/j.cllc.2011.11.008. Epub 2012 Jan 20. PubMed PMID: 22264659.
  111. Hoppe BS, Nichols RC, Henderson RH, Morris CG, Williams CR, Costa J, Marcus RB Jr, Mendenhall WM, Li Z, Mendenhall NP. Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger. Cancer. 2012 Sep 15;118(18):4619-26. doi: 10.1002/cncr.27398. Epub 2012 Jan 17. PubMed PMID: 22253020; PubMed Central PMCID: PMC3465790.
  112. Nichols RC Jr, Huh SN, Prado KL, Yi BY, Sharma NK, Ho MW, Hoppe BS, Mendenhall NP, Li Z, Regine WF. Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):158-63. doi: 10.1016/j.ijrobp.2011.05.045. Epub 2012 Jan 13. PubMed PMID: 22245197.
  113. Mendenhall NP, Schild S, Slater J. Radiation therapy modalities for prostate cancer. JAMA. 2012 Aug 1;308(5):450-1; author reply 451-2. doi: 10.1001/jama.2012.8112. PubMed PMID: 22851100.
  114. Hoppe BS, Flampouri S, Lynch J, Slayton W, Zaiden R, Li Z, Mendenhall NP. Improving the therapeutic ratio in Hodgkin lymphoma through the use of proton therapy. Oncology (Williston Park). 2012 May;26(5):456-9, 462-5. Review. PubMed PMID: 22730602.
  115. Hoppe BS, Flampouri S, Su Z, Latif N, Dang NH, Lynch J, Joyce M, Sandler E, Li Z, Mendenhall NP. Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma. Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):449-55. doi: 10.1016/j.ijrobp.2011.12.034. Epub 2012 Mar 2. PubMed PMID: 22386373.
  116. Hoppe BS, Flampouri S, Su Z, Morris CG, Latif N, Dang NH, Lynch J, Li Z, Mendenhall NP. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):260-7. doi: 10.1016/j.ijrobp.2011.06.1959. Epub 2011 Oct 17. PubMed PMID: 22014950.
  117. Williams C, Costa J, Mandia S, Henderson R, Marino R, Mendenhall N. Urethral catheterization facilitates preradiation fiducial marker placement in postprostatectomy patients. J Endourol. 2012 May;26(5):467-8. Epub 2012 Feb 3. PubMed PMID: 22141439.
  118. Nichols RC Jr, Morris CG, Hoppe BS, Henderson RH, Marcus RB Jr, Mendenhall WM, Li Z, Williams CR, Costa JA, Mendenhall NP. Proton radiotherapy for prostate cancer is not associated with post-treatment testosterone suppression. Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1222-6. Epub 2011 May 11. PubMed PMID: 21570206.
  119. Su Z, Lopatiuk-Tirpak O, Zeidan O, Sruprisan SI, Meeks SL, Slopsema R, Flampouri S, Li Z. An experimental investigation into the effect of periodic motion on proton dosimetry using polymer gel dosimeters and a programmable motion platform. Phys Med Biol. 2012 Feb 7;57(3):649-63. Epub 2012 Jan 12. PubMed PMID: 22241573.
  120. Dallas J, Imanirad I, Rajani R, Dagan R, Subbiah S, Gaa R, Dwarica WA, Ivey AM, Zlotecki RA, Malyapa R, Indelicato DJ, Scarborough MT, Reith JD, Gibbs CP, Dang LH. Response to sunitinib in combination with proton beam radiation in a patient with chondrosarcoma: a case report. J Med Case Rep. 2012 Jan 30;6:41. PubMed PMID: 22289277; PubMed Central PMCID: PMC3277477.
  121. Mendenhall NP, Li Z, Hoppe BS, Marcus RB Jr, Mendenhall WM, Nichols RC, Morris CG, Williams CR, Costa J, Henderson R. Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):213-21. Epub 2010 Nov 17. PubMed PMID: 21093164.
  122. Su Z, Zhang L, Murphy M, Williamson J. Analysis of prostate patient setup and tracking data: potential intervention strategies. Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):880-7. Epub 2010 Oct 8. PubMed PMID: 20934274; PubMed Central PMCID: PMC3020989.
  123. Mendenhall NP, Malyapa RS, Su Z, Yeung D, Mendenhall WM, Li Z. Proton therapy for head and neck cancer: rationale, potential indications, practical considerations, and current clinical evidence. Acta Oncol. 2011 Aug;50(6):763-71. Review. PubMed PMID: 21767172.
  124. Nichols RC, Huh SN, Henderson RH, Mendenhall NP, Flampouri S, Li Z, D'Agostino HJ, Cury JD, Pham DC, Hoppe BS. Proton radiation therapy offers reduced normal lung and bone marrow exposure for patients receiving dose-escalated radiation therapy for unresectable stage iii non-small-cell lung cancer: a dosimetric study. Clin Lung Cancer. 2011 Jul;12(4):252-7. doi: 10.1016/j.cllc.2011.03.027. Epub 2011 Apr 27. PubMed PMID: 21726825.
  125. Hoppe B, Henderson R, Mendenhall WM, Nichols RC, Li Z, Mendenhall NP. Proton therapy for prostate cancer. Oncology (Williston Park). 2011 Jun;25(7):644-50, 652. Review. PubMed PMID: 21888265.
  126. Su Z, Zhang L, Ramakrishnan V, Hagan M, Anscher M. Investigations of interference between electromagnetic transponders and wireless MOSFET dosimeters: a phantom study. Med Phys. 2011 May;38(5):2450-4. PubMed PMID: 21776780; PubMed Central PMCID: PMC3188601.
  127. Jin H, Hsi W, Yeung D, Li Z, Mendenhall NP, Marcus RB Jr. Dosimetric characterization of whole brain radiotherapy of pediatric patients using modulated proton beams. J Appl Clin Med Phys. 2011 Jan 19;12(2):3308. PubMed PMID: 21587172.
  128. Hoppe BS, Huh S, Flampouri S, Nichols RC, Oliver KR, Morris CG, Mendenhall NP, Li Z. Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy. Radiother Oncol. 2010 Dec;97(3):425-30. Epub 2010 Oct 9. PubMed PMID: 20934768.
  129. Mendenhall WM, Nichols RC, Henderson R, Mendenhall NP. Is radical prostatectomy the "gold standard" for localized prostate cancer? Am J Clin Oncol. 2010 Oct;33(5):511-5. Review. PubMed PMID: 20010078.
  130. Hoppe BS, Flampouri S, Li Z, Mendenhall NP. Cardiac sparing with proton therapy in consolidative radiation therapy for Hodgkin lymphoma. Leuk Lymphoma. 2010 Aug;51(8):1559-62. PubMed PMID: 20578823.
  131. Aldana PR, MacGregor TL, James HE, Marcus RB Jr, Indelicato DJ. Titanium screws as fiducial markers for image-guided stereotactic proton irradiation in pediatric central nervous system tumors: a technical report. Pediatr Neurosurg. 2010;46(3):227-31. Epub 2010 Nov 4. PubMed PMID: 21051922.
  132. Chera BS, Vargas C, Morris CG, Louis D, Flampouri S, Yeung D, Duvvuri S, Li Z, Mendenhall NP. Dosimetric study of pelvic proton radiotherapy for high-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):994-1002. Epub 2009 Jul 18. PubMed PMID: 19619961.
  133. Mendenhall WM, Henderson RH, Nichols RC, Keole SR, Mendenhall NP. Postprostatectomy radiotherapy for prostate cancer. Am J Clin Oncol. 2009 Oct;32(5):529-34. doi: 10.1097/COC.0b013e31817e6ef9. PubMed PMID: 19652581.
  134. Newlin HE, Indelicato DJ, Abbitt P, Marshall J, Wymer D, Grobmyer S, Haigh L, Copeland E, Morris CG, Mendenhall NP. Does surgical closure technique affect early mammographic detection of tumor recurrence after breast-conserving therapy? Am J Clin Oncol. 2009 Oct;32(5):499-503. doi: 10.1097/COC.0b013e318194f431. PubMed PMID: 19528792.
  135. Chera BS, Rodriguez C, Morris CG, Louis D, Yeung D, Li Z, Mendenhall NP. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy. Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1173-80. Epub 2009 Apr 20. PubMed PMID: 19386423.
  136. Hsi WC, Indelicato DJ, Vargas C, Duvvuri S, Li Z, Palta J. In vivo verification of proton beam path by using post-treatment PET/CT imaging. Med Phys. 2009 Sep;36(9):4136-46. PubMed PMID: 19810487.
  137. Mendenhall WM, Henderson RH, Indelicato DJ, Keole SR, Mendenhall NP. Erectile dysfunction after radiotherapy for prostate cancer. Am J Clin Oncol. 2009 Aug;32(4):443-7. Review. PubMed PMID: 19657239.
  138. Chera BS, Malyapa R, Louis D, Mendenhall WM, Li Z, Lanza DC, Yeung D, Mendenhall NP. Proton therapy for maxillary sinus carcinoma. Am J Clin Oncol. 2009 Jun;32(3):296-303. PubMed PMID: 19433966.
  139. Vargas C, Falchook A, Indelicato D, Yeung A, Henderson R, Olivier K, Keole S, Williams C, Li Z, Palta J. Proton therapy for prostate cancer treatment employing online image guidance and an action level threshold. Am J Clin Oncol. 2009 Apr;32(2):180-6. PubMed PMID: 19307953.
  140. Yeung AR, Vargas CE, Falchook A, Louis D, Olivier K, Keole S, Yeung D, Mendenhall NP, Li Z. Dose-volume differences for computed tomography and magnetic resonance imaging segmentation and planning for proton prostate cancer therapy. Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1426-33. Epub 2008 Aug 30. PubMed PMID: 18762391.
  141. Lin L, Vargas C, Hsi W, Indelicato D, Slopsema R, Li Z, Yeung D, Horne D, Palta J. Dosimetric uncertainty in prostate cancer proton radiotherapy. Med Phys. 2008 Nov;35(11):4800-7. PubMed PMID: 19070212.
  142. Vargas C, Wagner M, Indelicato D, Fryer A, Horne D, Chellini A, McKenzie C, Lawlor P, Mahajan C, Li Z, Lin L, Keole S. Image guidance based on prostate position for prostate cancer proton therapy. Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1322-8. Epub 2008 May 28. PubMed PMID: 18472365.
  143. Chvetsov AV, Palta JJ, Nagata Y. Time-dependent cell disintegration kinetics in lung tumors after irradiation. Phys Med Biol. 2008 May 7;53(9):2413-23. Epub 2008 Apr 17. PubMed PMID: 18421118.
  144. Vargas C, Wagner M, Mahajan C, Indelicato D, Fryer A, Falchook A, Horne D, Chellini A, McKenzie C, Lawlor P, Li Z, Lin L, Keole S. Proton therapy coverage for prostate cancer treatment. Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1492-501. PubMed PMID: 18374228.
  145. Vargas C, Fryer A, Mahajan C, Indelicato D, Horne D, Chellini A, McKenzie C, Lawlor P, Henderson R, Li Z, Lin L, Olivier K, Keole S. Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):744-51. Epub 2007 Sep 27. PubMed PMID: 17904306.
  146. Nichols Jr. RC, Henderson RH, Huh S, Flampouri S, Li Z, Bajwa AA, D'Agostino HJ, Pham DC, Mendenhall NP, Hoppe BS. Proton therapy for lung cancer. Thoracic Cancer 2012 May;3(2):109-116.
  147. Nichols Jr. RC, Huh S, Henderson RH, Li Z, Flampouri S, D'Agostino HJ, Cury JD, Pham DC, Mendenhall NP, Hoppe BS. Selective nodal irradiation of regionally advanced non-small-cell lung cancer with proton therapy and IMRT: A dosimetric comparison. Thoracic Cancer 2012 May;3(2):169-174.
  148. Shi W, Nichols RC, Flampouri S, His W, Li Z, Henderson RH, Mendenhall NP, Hoppe B. Tumour Shrinkage during Proton-based Chemoradiation for Non–small-cell Lung Cancer May Necessitate Adaptive Replanning during Treatment. Hong Kong J Radiol. 2011;14:190-4
  149. Figura N, Flampouri S, Hopper K, Marcus R, Mendenhall NP, Hoppe BS. Consolidative Proton Therapy Following High-dose Chemotherapy and Autologous Stem Cell Transplant in an Adolescent with Relapsed Hodgkin Lymphoma. JAYAO 2011 1(2): 103-6
  150. Shi W, Nichols RC, Flampouri S, Hsi W, Li Z, Henderson RH, Mendenhall NP, Hoppe BS. Tumor Shrinkage during Proton-based Chemoradiation for Non-small-cell Lung Cancer May Necessitate Adaptive Replanning during Treatment. Hong Kong J Radiol. 2011;14:190-4
  151. Nichols RC, Huh SH, Hoppe BS, Henderson RH, Li Z, Flampouri S, D'Agostino HJ, Cury JD, Pham DC, Mendenhall NP. Protons safely allow coverage of high-risk nodes for patients with regionally advanced non-small-cell lung cancer. Technol Cancer Res Treat. 2011 Aug;10(4):317-22. PubMed PMID: 21728388.
  152. Jin H, Palta JR, Kim YH, Kim S. Application of a novel dose-uncertainty model for dose-uncertainty analysis in prostate intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):920-8. Epub 2010 Jun 30. PubMed PMID: 20584579.
  153. Song WY, Huh SN, Liang Y, White G, Nichols RC, Watkins WT, Mundt AJ, Mell LK.  Dosimetric comparison study between intensity modulated radiation therapy and three-dimensional conformal proton therapy for pelvic bone marrow sparing in the treatment of cervical cancer. J Appl Clin Med Phys. 2010 Aug 15;11(4):3255. PubMed PMID: 21081882.
  154. Chvetsov AV, Paige SL. The influence of CT image noise on proton range calculation in radiotherapy planning. Phys Med Biol. 2010 Mar 21;55(6):N141-9. Epub 2010 Feb 24. PubMed PMID: 20182006.
  155. Chera BS, Rodriguez C, Morris CG, Louis D, Yeung D, Li Z, Mendenhall NP. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy. Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1173-80. Epub 2009 Apr 20. PubMed PMID: 19386423.
  156. Chvetsov AV, Dong L, Palta JR, Amdur RJ. Tumor-volume simulation during radiotherapy for head-and-neck cancer using a four-level cell population model. Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):595-602. PubMed PMID: 19596173.
  157. Hsi WC, Indelicato DJ, Vargas C, Duvvuri S, Li Z, Palta J. In vivo verification of proton beam path by using post-treatment PET/CT imaging. Med Phys. 2009 Sep;36(9):4136-46. PubMed PMID: 19810487.
  158. Hsi WC, Moyers MF, Nichiporov D, Anferov V, Wolanski M, Allgower CE, Farr JB, Mascia AE, Schreuder AN. Energy spectrum control for modulated proton beams. Med Phys. 2009 Jun;36(6):2297-308. PubMed PMID: 19610318; PubMed Central PMCID: PMC2832068.
  159. Paganetti H, Jiang H, Parodi K, Slopsema R, Engelsman M. Clinical implementation of full Monte Carlo dose calculation in proton beam therapy. Phys Med Biol. 2008 Sep 7;53(17):4825-53. doi: 10.1088/0031-9155/53/17/023. Epub 2008 Aug 13. PMID: 18701772.
  160. Vargas C, Wagner M, Indelicato D, Fryer A, Horne D, Chellini A, McKenzie C, Lawlor P, Mahajan C, Li Z, Lin L, Keole S. Image guidance based on prostate position for prostate cancer proton therapy. Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1322-8. doi: 10.1016/j.ijrobp.2007.12.016. Epub 2008 May 28. PMID: 18472365.
  161. Vargas C, Mahajan C, Fryer A, Indelicato D, Henderson RH, McKenzie C, Horne D, Chellini A, Lawlor P, Li Z, Oliver K, Keole S. Rectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Nov 15;69(4):1110-6. PubMed PMID: 17967305.
  162. Lu HM, Brett R, Engelsman M, Slopsema R, Kooy H, Flanz J. Sensitivities in the production of spread-out Bragg peak dose distributions by passive scattering with beam current modulation. Med Phys. 2007 Oct;34(10):3844-53. doi: 10.1118/1.2776255. PMID: 17985630.
  163. Vargas C, Fryer A, Mahajan C, Indelicato D, Horne D, Chellini A, McKenzie C, Lawlor P, Henderson R, Li Z, Lin L, Olivier K, Keole S. Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):744-51. doi: 10.1016/j.ijrobp.2007.07.2335. Epub 2007 Sep 27. PMID: 17904306.
  164. Slopsema RL, Kooy HM. Incorporation of the aperture thickness in proton pencil-beam dose calculations. Phys Med Biol. 2006 Nov 7;51(21):5441-53. doi: 10.1088/0031-9155/51/21/004. Epub 2006 Oct 6. PMID: 17047262.
  165. Kooy HM, Rosenthal SJ, Engelsman M, Mazal A, Slopsema RL, Paganetti H, Flanz JB. The prediction of output factors for spread-out proton Bragg peak fields in clinical practice. Phys Med Biol. 2005 Dec 21;50(24):5847-56. doi: 10.1088/0031-9155/50/24/006. Epub 2005 Dec 6. PMID: 16333159.